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The natural history of lung function is characterized by various stages of development. 
The first phase includes lung function increasing to a peak around young adulthood 
followed by a plateau phase, and finally a physiological decline with age. Early-life 
lung function predicts later lung function and events that happened during the lifespan 
might influence the lung function trajectories of an individual, resulting in poorer lung 
health. The fetal and the first years of life are considered vulnerable periods in which 
the lungs undertake rapid and dramatic changes. Investigating early life risk factors and 
their impact on lung function trajectories from childhood to young adulthood is 
critically important as a first step in preventing long term lung impairments. Indeed, 
there is the need to further understand which risk factors are involved in the impairment 
of lung function trajectories. 
 
With this thesis, I aimed to characterize lung function trajectories and investigate early-
life predictors related to low lung function trajectories identified. A total of 1512 
participants with at least two spirometry measurements were investigated using data 
from the Raine Study.  Lung function trajectories for FEV1, FVC and FEV1/FVC (z-
scores) were identified using group-based trajectory modelling for data available at 6, 
14- and 22-year follow-ups. Multivariable analysis for childhood, parental and 
environmental risk factors was assessed using multinomial logistic regression. We 
identified four lung function trajectories for FEV1, FVC and FEV1/FVC. Associations 
were found between low lung function trajectories of FVC and asthma (p=0.024), 
maternal smoking (p=0.015), and parental asthma (p=0.024). Childhood wheeze was 
associated with the very low trajectory of FEV1 (p=0.042) and females were more 
likely to belong to the low trajectory of FVC compared with males (p=0.026). Early-




This study provides evidence of a group of the population that followed a persistently 
low lung function trajectory, characterized of having asthma, wheeze, mothers smoke 
in pregnancy and during childhood, parental asthma and that may be partly established 
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Literature review and introduction 
 
 
1.1 Introduction  
Lung function is a recognized marker of respiratory health. Respiratory diseases are a 
leading cause of mortality and disability in the world, accounting for more than 13% 
of the active and productive life lost due; commonly referred to as disability adjusted-
life-years (DALYs) (European Respiratory Society, 2017). To prevent and control 
these diseases over the lifespan it is crucial to identify which risk factors have an impact 
on the respiratory health of the population. According to the Development Origins of 
Health and Disease (DOHaD) concept that was firstly explained by Barker and 
colleagues (1989), our health is influenced by the environment and by events that 
happen in sensitive developmental periods, such as in utero and in early childhood 
(Wadhwa et al., 2009). 
 
A wide range of studies have been conducted to investigate this theory, and it has been 
shown that determinants of chronic respiratory diseases, such as asthma and chronic 
respiratory obstructive diseases (COPD), have associations with insults that occur as a 
result of pre- and post-natal exposures (Stern et al., 2008; Maritz & Harding, 2011; Sly 
P., 2011). If negative events occur during these years in which the lungs are still 
developing, they might change the structure of the lungs, influencing lung function over 
the life course. Although studies have investigated the association between lung 
function and early-life predictors, most of them have focused on acute rather than long-
term consequences. Thus, it is not clear how the early life period and which specific 




This Chapter presents a review of the literature focused on the association between lung 
function and risk-factors in pre- and early post-natal life. To begin with, in the 
following sections I focus on the role of the lungs and the mechanism and development 
of lung function. Then, I review which risk factors have been associated with lung 
function impairments over the life span. The research gaps are identified, which leads 
to the formation of the research aims for my doctoral work.  
 
 
1.2. Lung physiology and development 
The respiratory system is one of the primary interfaces between the organism and the 
environment. Lungs are the essential organs of the respiratory system, together with 
the nose, oropharynx, larynx, trachea, bronchi, and bronchioles. The bronchi branch 
into progressively smaller airways until they terminate into the alveoli, that are the 
primary location of gas exchange (Figure 1.1). The oxygen enters in the lugs and it is 




Figure 1.1. Structure of the lungs.  
 
(OpenStax) 
Note*  a) The tracheobronchial tree is the passageway from the mouth to the interior of the lungs b) gas 
exchange occurs in the alveoli deep into the lungs c) the lungs exchange oxygen and carbon dioxide 
between the air and the blood.  
 
 
Lung development starts in utero, as early as 3 weeks of embryonic life and continues 
to adolescence into early adulthood (GOLD, 2017), reaching a peak at 20-25 years of 
age. During early in utero life, the epithelial cells invade the surrounding mesenchyme 
to form the trachea, that branches into the main bronchi. In normal conditions, by 14 
weeks, nearly 70% of the conducting airway tree present at birth has formed. Then, the 
acinar structures including the respiratory bronchioles, alveolar ducts and primitive 






weeks of in utero life, establishing a possible platform for gas exchange. At around 28 
to 36 weeks of intrauterine life, division of the airways is almost complete. The 
formation of double capillary walled secondary septa and multiplication of alveoli 
starts at around 36 weeks in utero and continues in the post-natal phase at least up to 
two- four years of age.  It has been estimated that the number of alveoli at birth ranges 
from 20 - 50 million, and studies have reported that the number of alveoli in a fully 
developed adult lung reach around 300- 800 million (Joshi & Kotecha, 2007). Lung 
growth is completed at about 18 years in women and at about 20 years in men. The 
different phases of lung development are summarized in Figure 1.2.  
 
Figure 1.2. Principle stages of lungs development  
 
(Iliodromiti et al., 2013) 
Note* The major structures of the lung develop through the embryonic (0-7 weeks), pseudoglandular (8-
17 weeks), canalicular (18-27 weeks), saccular (28-36 weeks), and alveolar (37 weeks- 2 years) stages 




1.2.1 Lung function  
Normal lung function development is characterized by crucial physiological phases 
through the life course, as a consequence of structural changes of the lung. These 
include a growth phase that reach the peak during early adulthood and a plateau phase 
followed by a steady decline due to aging (GOLD, 2017). As described in the previous 
section, during the lifetime and advancing with age, the lung undertakes structural and 
functional changes. These changes include a decrease in lung function, pulmonary 
remodeling, limited regeneration, and enhanced susceptibility to pulmonary diseases in 
people >65 years. Even in healthy individuals, lung function decreases with the age. 
Lung size is strongly associated with body size, dimensions of the thoracic cavity, sex, 
and age. Indeed, during childhood and adolescence, lung function increases 20-fold 
during the first 10 years of life, due to the fast growth of the lung (GOLD, 2017). One 




Spirometry is a reproducible and noninvasive lung function test (Moore, 2012).  It is 
largely used to provide objective information for the diagnosis of lung diseases and 
monitoring lung health. The use of spirometry is fundamental to assess general 
respiratory health (Graham et al., 2019) and to check for respiratory abnormality.  
 
The main reported outcomes in spirometry are a) Forced expiratory volume in 1 second 
(FEV1), that is the maximal volume of air exhaled in the first second of a forced 
expiration from a position of full inspiration. FEV can be reported at any given time, 
i.e. FEV0.50 and FEV0.75 are commonly used among young children where the lungs are 
less compliant; b) Forced vital capacity (FVC) that is the maximal volume of air 
exhaled with maximally forced effort from a maximal inspiration. c) FEV1/FVC, that 
is the FEV1 expressed as a percentage of FVC and gives a clinical index of airflow 
limitation; d) FEF25-75%, that is the average expired flow over the middle half of the 
FVC maneuver and is often regarded as a measure of small airway narrowing; e) Peak 
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expiratory flow (PEF), is the maximal expiratory flow rate achieved and occurs very 
early in the forced expiratory maneuver; f) Forced expiratory flow at 50% or 75% FVC 
(FEF50% and FEF75%), that is the maximal expiratory flow measured at the point where 
50% of the FVC has been expired (FEF50%) and after 75% has been expired (FEF75%); 
g) FVC6, that is the forced expiratory volume during the first six second and is a 
surrogate of the FVC.  
 
 
1.2.1.2. Standardization of spirometry 
The major determinants of spirometric lung function are age, height, sex, and ethnicity. 
To facilitate the interpretation and comparison of spirometry, the results are compared 
to predicted values appropriate for individual being testes and standardized to the 
healthy population (GOLD, 2017). Recently, the Global Lung Function Initiative (GLI) 
addressed this issue and developed a global approach with the aim to standardize how 
lung function is interpreted worldwide (Cooper et al., 2017.). The main objective of the 
GLI was to derive “all-age” reference equations for spirometry from pre-school 
children to the elderly covering as many ethnic groups as possible. The GLI-2012 
equations (Quanjer et al., 2012) have been approved by all major respiratory societies 
and have been validated in several populations, including Caucasian Australasians 
(Hall et al., 2012). These equations quote the various coefficients for age, height, and 
the residual standard deviation (RSD; standard error of the estimate) for the prediction. 
The range of values obtained from the healthy population is assumed to represent 
normal. Both the American Thoracic Society (ATS) and European Respiratory Society 
(ERS) recommend the use of the lower limit of normal (LLN), or upper limit, to define 
between health and suspected disease. By convention, the LLN is set at 5%, where 90% 
of the healthy population fall within the normal range. The normal range can be 
represented as a pictogram (Figure 1.3.), or as z-scores, in which 90% of healthy 
population will have a Z-scores values within ±1.64 z-scores. The z-score indicates 
how many standard deviations a measured value is from the predicted, removing the 


















Stanojevic et al., 2013 
 
Note* The horizontal bars demonstrated the normal range (white region), with arrows indicating how 
far from the normal range an observation is (z-scores). The normal range can be represented as z-
scores in which 95% of healthy individuals have a z-scores within ±2 z-scores, and 90% within ±1.64 
z-scores.  
 
1.3.  Lung function trajectories 
It has been shown that early lung function predicts later lung function and that different 
pathways may exist (Agusti & Faner, 2019). A variety of factors associated with both 
the environment and life- style that are present from the fetal period into adulthood may 
impact the natural lung function growth, resulting in abnormal lung function 
trajectories. Further, peak lung function reached in early adulthood has been reported 
to predict a diagnosis of chronic obstructive pulmonary disease (Lange et al., 2015) and 
to all-cause of mortality (Weinmayr et al., 2020). This may be either the consequence 
of an accelerated decline in lung function during adult life or the results of impaired 
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lung growth during childhood or in utero (Vasquez et al., 2017) Therefore, it is relevant 
to explore which factors influence lung function development, especially in childhood.  
 
Characterizing lung function trajectories may help to recognize abnormal patterns and 
identify risk factors for impaired respiratory outcomes in later life. This is essential for 
early detection and prevention. As pointed out by Karmaus and colleagues (2019) most 
of the previous studies that analyzed lung function development over time used an 
arbitrary cut-off point of individual variability about the mean. This method does not 
allow us to identify unknown trajectories. Indeed, recently, more advanced statistical 
methods were used to identify trajectories. Most recent studies on lung function 
identified latent classes, but not trajectories addressing development over time. One 
study analyzed lung function trajectories allowing for non-linear development of lung 
function in individuals (Bui et al., 2018). 
 
Studies on lung function development have been reported using different lung function 
outcome, where FEV1 was the most investigated. Two studies investigated the 
FEV1/FVC ratio, while other parameters explored were FVC, FEF25-75. However, to the 
best of our best knowledge, none has examined trajectories of FEV1, FVC and 
FEV1/FVC expressed as z-score. These outcomes have been hypothesized to be the 
most clinical meaningful approach, especially when measured the parameters over 
time. 
Longitudinal studies with measurements at various time points are essential to study 
individual lung function development over time. In the longest study, Bui et al (2018) 
using data from the Tasmanian Longitudinal Health Study (TAHS) analyzed FEV1 lung 
function trajectories in individual followed from 5 to 53 years. Indeed, all the other 
studies investigated participants from adolescence to adulthood, while others 
investigated lung function trajectories in participants from 23 to 30 years (McGeachie 
et al., 2016) and from 3 to 11 years (Belgrave and colleagues, 2016). All these 
researchers found between two and three lung function trajectories, whereas Bui and 
colleagues (2018) found six trajectories, two of which had been never previously 
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characterized: early below average, accelerated decline and early low, accelerated 
growth, normal decline. These newer trajectories may be due to the longer time frame 
studied with the consequent ability to characterize the lung function trajectories 
decline. To summarize, it has been demonstrated that there are different trajectories of 
lung function in the general population, and that belonging to low lung function 
trajectories might lead to respiratory diseases later in life. Further, no studies 
investigated all the three respiratory outcomes from a wide period from childhood to 
adulthood.   
 
1.4. Respiratory diseases 
Lung diseases are mainly categorized as obstructive or restrictive diseases. In the next 
section a brief description of these diseases and their relationship with lung function 
trajectories will be described.  
 
1.4.1. Obstructive lung diseases 
Obstructive lung diseases are major global health problems, with asthma and chronic 
obstructive pulmonary disease (COPD) being the two main contributors. Reduced 
maximal attained lung function, as measured by spirometry, may identify individuals 
who are at risk for developing COPD (GOLD, 2017).  
 
Asthma is a heterogeneous condition in both children and adults and the most common 
chronic condition among children around the world and in Australia, accounting for a 
consider burden of disease (National Asthma Council Australia, 2018; Global Initiative 
for Asthma, 2020). Most asthma starts in early childhood and around 95% of asthma 
patients have their first episode before preschool age (Papi et al., 2018). The disease is 
characterized by various respiratory symptoms, such as wheezing, shortness of breath, 
chest tightness, and cough, as well as variable airflow limitation. These features can be 
caused by numerous mechanisms that are often associated with airway inflammation 




Recently, different groups of patients with similar clinical characteristics have been 
defined, leading to the identification of different asthma phenotypes. Childhood-onset 
allergic asthma is often associated with eczema, rhinitis, food allergy, a family history 
of allergy and asthma, wheeze and with viral respiratory infections and tobacco 
exposure. Non-allergic asthma can present at any age, and in children is more likely to 
resolve in adolescence. Late-onset asthma is considered when asthma symptoms appear 
for the first-time after the completion of puberty and is common in females. However, 
definitions are varied and can refer to onset as early as 12 years of age or as late as over 
65 years and is often underdiagnosed. This type of asthma is often non-atopic, more 
severe and associated with a more rapid decline in lung function. Occupational asthma 
is another type of asthma induced by occupational exposure to allergens or irritants and 
is sometimes preceded by rhinitis. Although evidence for a causative role is not 
exhaustive, asthma might be a risk factor for subsequent development of chronic 
airflow limitation and COPD (Silva, Sherrill, Guerra, & Barbee, 2004). 
 
Chronic respiratory pulmonary disease is a common, preventable, and treatable disease 
characterized by persistent respiratory symptoms and airflow limitation. The disease is 
currently the fourth leading cause of morbidity and mortality worldwide and is 
projected to increase over time (GOLD, 2017). The airflow limitation or obstruction in 
COPD is caused by a mixture of small airway disease, parenchymal destruction and, in 
some cases, asthma. Chronic inflammation of the lungs leads to structural changes, 
restriction of the small airways and destruction of the lung parenchyma. These changes 
reduce the ability of the airways to remain open during expiration. Reduced maximal 
attained lung function, as measured by spirometry, might identify individuals with 
higher risk for the development of COPD. A recent study (Lange, Celli, Agustí, Jensen, 
et al., 2015) suggested that lung function value reached in early adulthood was 
associated with diagnosis of COPD in later life. The diagnostic criterion for COPD is 
based on spirometry confirming a reduction in the FEV1/FVC ratio below 0.7, or below 
the lower normal limit. However, even in healthy individuals lung function declines 
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with age. Thus, the use of a fixed cut-off might result in overdiagnosis of COPD in the 
elderly and underdiagnosis in the youngest (Ho et al., 2019).  
 
The Fletcher-Peto assumption on the normal lung function decline states that all 
individuals attained a normal lung function in young adulthood, followed by a rapid 
decline, where smoking was the main determinant (Fletcher & Peto, 1977). However, 
this hypothesis has been expanded in recent years. Specifically, the study conducted by 
Lange and colleagues (2015) on three large independent cohorts showed that an 
accelerated decline in lung function was not a characteristic feature in all participants 
who developed COPD. In fact, they found two main trajectories of lung function 
decline with age: one associated with normal initial lung function and a second with 
low lung function attainment in young adulthood. With this concept in mind, the 
pathogenesis of COPD needs to be investigated also in individuals whose low lung 
function trajectory starts in early life.  
 
Few longitudinal studies attempted to investigate the childhood origins of COPD, 
identifying early risk factors associated with airflow obstruction later in life. In the 
Childhood Asthma Management cohort (McGeachie, 2016), 11% of participants with 
abnormal lung function trajectories at their last spirometric session (mean age, 26.0±1.8 
years) met the criteria for COPD in early adulthood. Further support for this came from 
Bui and colleagues (2018) that used data from the Tasmanian Longitudinal Health 
Study and reported that 75% of COPD cases at 53 ages were attributable to the three 
low lung function trajectories of FEV1 that they identified.  
 
Many studies suggest that asthma may lead to COPD or persistent airflow obstruction 
or is a risk factor for COPD. Indeed, findings from 20 years of follow up using the 
Tucson Epidemiologic Study of Airway Obstructive disease (TESAOD) showed that 
adults participants with current asthma were almost 13 time more likely to fulfill COPD 
criteria, even after adjusting for smoking status and other potential confounders (Silva 
et al., 2004). Similarly, in the analyses performed using the large European Community 
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Respiratory Health Survey (ECRHS), Svanes and colleagues showed that children with 
asthma had a 10-fold increased risk of developing COPD later in life (Svanes, 2010) 
 
All these findings provide insight into the origins of obstructive lung diseases and 
emphasize the importance of investigate early risk factors or adverse exposures that 
might lead to poorer lung function trajectories that might track into adulthood. 
 
 
1.4.2. Restrictive lung diseases 
Restrictive lung diseases are a rarer heterogeneous group of conditions that impair lung 
expansion and characterized by a reduction in lung volume and worsens with age 
(Burke et al., 2012). With the impaired lung expansion of restrictive lung disease, there 
is decreased compliance and vital capacity of the lungs, chest wall or both. This occurs 
in pulmonary fibrosis, pleural disease, chest wall disorders, neuromuscular disorders, 
pneumonectomy, pulmonary oedema and obesity. A restrictive pattern on spirometry 
is defined by a reduction in FVC, without bronchial obstruction, less than the LLN. If 
the FEV1/FVC ratio is ≥ LLN and FVC is <LLN, a restrictive pattern is suggested, and 
it should be confirmed evaluating the total lung capacity (Brazzale, Hall, & Swanney, 
2016). To the best of our knowledge, no studies assessed the association between lung 
function trajectories and risk factors associated to restrictive lung diseases. 
 
 
1.5 Early life risk factors of low lung function 
Factors associated with both the environment and lifestyle during crucial periods, such 
as fetal, post-natal, and childhood can lead to permanent, physiological, structural, or 
epigenetic changes that persist over the life course (Chen & Zhang, 2012). While 
prenatal factors are more likely to impair airway development, postnatal factors are 
more likely to affect the airway growth, alveolarization, and microvasculature. The risk 
factors implicated in poor lung health include respiratory infections, environmental 
tobacco smoke, adverse dietary intake, premature birth, obesity, air pollution and 
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asthma (Stocks & Sonnappa, 2013) and the evidence relating to these risk factors and 
lung function trajectories are reviewed below. 
 
 
1.5.1. Respiratory infections 
Respiratory tract infections account for a large proportion of childhood illness through 
the world, with 156 million new episodes of pneumonia per week worldwide in 
children aged less than 5 years (WHO, 2019). Evidence is growing suggesting that 
respiratory infections in early life lead to a decline in lung function or medium and 
long-term development of asthma (Jackson & Lemanske, 2010). However, although 
respiratory infections can affect the lungs in many ways, not all individuals who 
contract a respiratory infection experience an asthma exacerbation.  
 
Respiratory syncytial virus (RSV), rhinovirus (RV) and Influenza, are the most 
common and important causes of lower respiratory tract infections (LRTI) in young 
children together with others (Figure 1.4.). While most children become infected during 
the first years of life, the illnesses from respiratory tract infections can range from 
asymptomatic infections to pneumonia or bronchiolitis that may lead to hospitalizations 




Figure 1.4. Virus etiology from bronchiolitis to asthma in childhood 
  
 (Jartti, Bønnelykke, Elenius, & Feleszko, 2020) 
Note* RSV, respiratory syncytial virus; RV, rhinovirus; hBoV, human bocavirus; Flu, influenza 
virus; EV, enteroviruses; MPV, metapneumovirus; PIV, parainfluenza virus; AdV, adenovirus 
 
There is the chance that certain risk factors increase the susceptibility to present with 
wheeze after viral infections occur. In a birth-cohort population of 285 children at 
increased risk to develop allergies and asthma, having respiratory infections during 
infancy was one the main risk factors for the development of subsequent wheezing at 
3 years of age (Lemanske et al., 2005). Existing evidence supported the association 
between respiratory infections and asthma. However, whether symptomatic low 
respiratory tract infections are causal in asthma development, or if it is a marker of 
susceptibility identifying predisposed children remains unclear. 
 
Various studies support the hypothesis that respiratory infections, particularly those 
resulting in pneumonia and bronchitis, lead to diminished FEV1. In the Tucson Cohort, 
Berry and colleagues (2016) identified that LRTI caused by RSV in the first three years 
of life represented a risk factor for having a lower lung function trajectory. Svanes and 
30 
 
coauthors (2010) found that severe respiratory infections before the age of 5 years were 
associated with a lower adult FEV1 level, that might contribute to develop COPD. 
Lopez and colleagues (2013) showed that LRTI experienced between birth and 5 years 
of age were associated with reduced lung function measurements at age 25 for FEV1, 
FVC, FEV1/FVC, FEF25%-75%, and PEF. Allinson and colleagues (2017) in an 
epidemiological study in a population aged between 43 and 64 years, found that 
participants with adverse exposure in early life, such as LRTI, had a decrease in FEV1 
in adulthood, only if they had smoked. 
Although there are few epidemiological studies that agreed on the fact that childhood 
respiratory infections are predictors for unfavorable lung function later in life, their 
implications on adult respiratory health are still limited and unclear. Further, there is a 
disagreement as to how this relationship changes in relation to the age in which 
infections are experienced and if the infections are whether associated with obstructive 
or restrictive deficits or if it also occurs with upper respiratory tract infections (Lopez 
Bernal et al., 2013). Although the impact of childhood respiratory infections on lung 
function decline has been established, their implications in adult lung function remain 
uncertain.  
 
1.5.2. Air pollution 
Exposure to air pollution contributes to mortality and morbidity and it is an important 
cause of the global disease burden (Kim et al., 2018; Künzli et al., 2010). Further, it is 
known as one of the most important determinants of lung function, especially in 
vulnerable subgroups, such as children and in those with asthma (Losacco & Perillo, 
2018). Negative health effects of air pollutants have been shown on multiple respiratory 
diseases, including respiratory infections, asthma, COPD, and lung cancer (Wu et al., 
2018). 
 
Although the polluting substances dispersed in the atmosphere are numerous, the major 
pollutants in the atmosphere include particulate matter (PM), ozone (O3), nitrogen 
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oxide (NOx), sulfur dioxide (SO2) and volatile organic compounds (VOCs) (Wu et al., 
2018). Sulphur dioxide belongs to the family of sulphur oxide gases (SOX) and is 
present in raw materials including crude oil, coal, and the ores of common metals, as 
aluminum, copper, zinc, lead, and iron. SOX gases are formed when fuel containing 
sulphur is burned, when gasoline is extracted from oil and when metals are extracted 
from ore.  NOX is the generic term of a group of highly reactive gases, all of which 
contain nitrogen and oxygen in varying proportion. NOX are emitted primarily because 
of high temperature combustion. Road traffic is a dominant source of NOX. VOCs are 
organic chemical compounds that have sufficiently high vapor pressures under normal 
conditions to vaporize significantly and enter the atmosphere.  
 
Atmospheric particulate matter (PM) is a complex mixture of primary and secondary 
extremely small particles and liquid droplets containing acids, organic chemicals, 
metals, and soil or dust particles (Losacco & Perillo, 2018). Primary PM is generated 
from road transport, combustion (mainly coal burning), and other industrial processes, 
whereas secondary PM is generated through chemical reactions among different 
primary particulates in the atmosphere (Xing et al., 2016). Its pathogenicity is 
determined by their size, composition, origin, solubility, and their ability to produce 
reactive oxygen. Although the bronchopulmonary tract consists of various protective 
mechanism, such as the mucosa cilia and air blood barrier, air pollutants can 
accumulate in or pass through lung tissue depending on their size and their chemical 
nature. 
 
According to their diameter size, PM are classified into:PM2.5, with a diameter ≤ 2.5 
µm and PM10, with a diameter ≤ 10 µm. The vapor of air pollutants tends to be absorbed 
by human tissues or dissolved in body fluids. Particulate matter with larger size (~10 
µm) can reach the proximal airways and be mostly eliminated by mucociliary 
clearance. Smaller particulate matter referred to fine (PM with a diameter ≤ 2.5 µm) 
and ultrafine particles (with a diameter < 100nm, PM0.1) can transit more deeply into 
the lungs (Mortimer et al., 2008). Due to their small size, they have a life-time of days 
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to weeks and can transport over thousands of kilometer distance. The fine particulate 
matters are respirable, and are small enough to travel into respiratory tract, can 
penetrate deeply into the lung, irritate, and corrode the alveolar wall, and consequently 
impair lung function. Although these ultrafine particles can be observed in many 
organs, their deposition patterns show that lungs are the primary site (Wu et al., 2018) 
and pre- and post- natal effects on lung function have been investigated. There is 
growing awareness of the adverse effects of both prenatal and postnatal exposure to air 
pollution. Evidence of air pollution exposure on lung function are reviewed below.  
 
 
1.5.2.1. Prenatal exposure to air pollution 
Few studies have examined the association between exposure to ambient air pollution 
in utero and lung function over the lifespan. Mortimer and colleagues (2008) conducted 
a population-based study analyzing data of 232 asthmatic children from the Fresno 
Asthmatic Children’s Environment cohort. They explored the association between 
exposure to air pollutants during pregnancy and lung function at 6-11 years, showing 
that exposure to NO2 in the second trimester of gestational period was associated with 
a decrease in both FVC and FEV. First trimester exposure to PM10 negatively affected 
PEF rate, while second trimester exposure to PM10 had a negative effect on forced 
expiratory flow at 25% of FVC. Prenatal exposure to Carbon monoxide (CO) was 
negatively associated with FEF25-75. Similarly, using advanced Bayesian statistical 
methods, Bose et al (2018) investigated the exposure to NO3 during the gestational 
period on lung function at age 7. The authors reported that an increase in NO3 exposure 
between 6 and 12 weeks of pregnancy was associated with a reduction in FEV1 in 
preschoolers, with a higher effect in boys. Similar reductions were seen for FVC. In a 
prospective birth cohort study of 241 healthy infants, each increase of 1 µg·m3 in PM10 
during pregnancy was associated with an increase in minute ventilation of 24.9% at 
five weeks of age (Latzin et al., 2009). Other studies found also that prenatal exposure 
to PM2.5 was strongly associated with wheezing in the first 2 year of life (Morgenstern 
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et al., 2007) and that higher exposure to ambient air pollution in early life was 
associated with elevated risk of asthma diagnosis in preschool age children. 
 
 
1.5.2.2. Early postnatal exposure to air pollution 
Both cross-sectional as well as longitudinal studies have clearly shown diminished lung 
function in children with a short- and long-term exposure to air pollutants. However, 
findings are controversial. Some studies reported associations with FEV1, whereas 
others showed association with FVC, or with both lung volume and expiratory flow 
and others found no association at all.  
 
A review by Götschi and colleagues (2008) concluded that there is evidence for small 
adverse effect of outdoor air pollution on lung function in children and adolescents. A 
birth cohort study conducted on 1185 children of elementary-school age from the 
Manchester Asthma and Allergy Study (MAAS) birth cohort aimed to investigate the 
long-term effect of exposure to PM10 and to NO2 on specific airway resistance and 
FEV1 (2013). The authors found a statistically significant impairment in growth of 
FEV1 with an increase in exposure to both air pollutants. Although the reduction in 
FEV1 growth was small, and may had little impact on healthy individuals, the authors 
speculated that they could had more implications for susceptible individuals, as those 
with COPD or in children who will go on to smoke cigarettes. At present, there is a 
large difference among studies regarding the study design and exposure assessment. 
However, a meta-analysis conducted by Gehring et al. (2013) explored the association 
between individual residential exposure to air pollution and lung function, using 
common exposure assessment and statistical analysis protocols across five European 
birth cohort. They found that estimates levels of NO2, NOX, PM2.5Absorbance and PM2.5 
were associated with a small decrease in lung function in a population of school 
children. While most of the studies are conducted on high levels of air pollution 
concentrations, a population-based cross-sectional was carried out in an area in which 
the level of air pollutants was relatively low, using data from 2630 Australian children 
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aged between 7 and 11 years. The concentrations of NO2 in the last 12 months were 
associated with a reduction in both FEV1 and FVC, and an increase in FENO (Knibbs et 
al., 2018). Indeed, another study found similar results with regards to FEV1, but the 
association was stronger in males compared to females (Gehring et al., 2013). Fuertes 
and colleagues (2015) assessed the association between residential exposure to air 
pollution and lung function in 2266 children in two German birth cohorts. They found 
that long-term exposure to air pollutants was not associated with lung function. 
However, a significant negative association for NO2 was observed among asthmatics. 
Similarly, in a large population-based survey conducted in Germany, Nicolai et al 
(2003) found that no significant association of traffic counts on lung function. More 
recently research (Shao et al., 2020) investigated the effect of high-level of PM2.5 
exposure during a bushfire episode in children aged less than two years of age. 
Interestingly, at three-years of follow up, they had worse peripheral lung mechanics. 
These findings suggest that even if these children will be able to recover their 
respiratory over the years, the early-life exposure to a short period of air pollution might 
compromise their lung growth and development.  
 
Although the association between in utero and post-natal exposure of air pollution and 
declined lung function has been established, findings are controversial and respiratory 
outcomes later in life might vary for different pollutants. Further, most of the studies 
have been conducted in areas where air pollution concentrations are high, while less is 
known relating to areas at low concentration levels.  
 
 
1.5.3. Environmental tobacco exposure  
There have been a wide range of studies showing that exposure to tobacco smoke in 
pregnancy or in early life is associated with impairment in lung function or increases 
in respiratory symptoms in childhood (Wang et al., 2020). In addition, it has been 
reported to result in negative pregnancy outcomes, such as low birth weight and 





1.5.3.1. Prenatal exposure to smoke  
Maternal smoking during pregnancy is considered one of the largest risk factors for 
abnormal lung development (Stocks & Sonnappa, 2013). Despite the incidence of in 
utero smoking decreasing in the past decade (Zacharasiewicz, 2016), about 10% of 
women in Australia who gave birth still smoked in the first 20 weeks of pregnancy 
(Australian Government, 2019). A wide range of cohort studies investigated the 
association between in utero smoking and lung function. A study on 803 healthy infants 
in Norway (Lødrup et al., 1997) reported that babies of smoking mothers had impaired 
flow volume curves compared to babies of non-smoking mothers. Gilliland and 
colleagues (2003) showed that non-asthmatic children with a history of in utero smoke 
exposure, had decreased FEV1/FVC ratio, FEF25-75, and FEF25-75/FVC ratio. Further, it 
has been shown that children exposed to in utero smoke and having early onset asthma 
reported deficits in FEV1, and FEF25-75 among boys; and FEF25-75 among girls. The 
authors speculated that in utero exposure and early onset asthma are associated with 
persistent impairment on lung function, suggesting that children with early onset 
asthma might be a high-risk group for develop respiratory deficits over life. A 
longitudinal birth cohort study conducted on 2409 young adults (Hayatbakhsh et al., 
2009) investigated the association between in utero exposure to maternal smoking and 
poorer lung function in early adulthood. They found that prenatal exposure to maternal 
smoking was associated with a reduction in the small airway flow rates in males.  Stick 
and colleagues (1996) reported that newborns with a family history of asthma had 
larger deficits in lung function from in utero exposure compared with those without a 
family history of asthma.  
Recent studies showed that maternal smoking have an intergenerational effect. Various 
studies reported also that grandmaternal smoking increased the risk of maternal asthma 
and, even if the mother herself does not smoke, it increased the risk of her offspring of 




With regards to lung development, most research has focused on the effect of nicotine 
in pregnancy on the child. One of the most important effect of nicotine is its role in 
altering the structural development of the lung. The alveoli are bigger, and a potential 
mechanism for reduced lung function is a reduction in the number of alveolar-
bronchiolar attachment points, with the consequence of a reduction in alveolarization. 
In animal models, it has been demonstrated that fetal exposure to nicotine leads to a 
reduction in the surface complexity of the lung parenchyma, increased collagen 
accumulation, upregulated surfactant protein gene expression and induction of neuro-
endocrine cell hyperplasia in fetal lungs, with the consequence of lung function 
reduction (Maritz & Harding, 2011). Environmental tobacco smoke exposure often 
begins in utero with maternal smoking. However, the effects of postnatal tobacco 
smoke exposure may also lead to poorer respiratory health.   
 
 
1.5.3.2. Early postnatal exposure to secondhand smoke 
Early postnatal exposure to secondhand smoke is considered a risk in reducing lung 
function in young children. However, findings are controversial. In a large cohort of 
1505 preschool children, Leung and coauthors (2013) found that children exposed to 
environment tobacco, quantified by urine cotinine levels, had FEV0.5, FEV25-75, and 
PEF lower than unexposed children. A meta-analysis of over 70 studies performed by 
Burke and coauthors (2012) summarized that postnatal maternal smoking was 
associated with significantly increased risks of onset of wheeze and asthma in children. 
The study found that passive smoke exposure was associated with a 20% to 85% 
increased risk of incidence of asthma. However, in a prospective study in 2295 
children, early life exposure to secondhand smoke was not associated with lung 
function in infancy or at age 16 (Thacher, 2018). In a study with data from derived 
from the Mater University of Queensland Study of Pregnancy (MUSP), Hayatbakhsh 
and colleagues (2009) reported that exposure to maternal smoking between six months 




Although studies provided evidence of the association of in utero smoking and lung 
function decline in children, there is no clear evidence that postnatal exposure to 
maternal smoking has an independent effect on the child’s lung function. In fact, there 
have been difficulties in separate the effect of prenatal and post-natal tobacco smoke, 
since women who smoke during pregnancy might continue to smoke after the birth of 
the child. Further, evidence is emerging in reporting that smoking in the previous 
generations can influence the risk of asthma in the offspring.  
 
 
1.5.4. Allergens  
Allergens have been consistently reported as a risk factor for bronchial 
hyperresponsiveness and asthma in children and adulthood (Nelson, 2000). The most 
common way to define atopy is by the skin prick test (SPT) or by the presence of 
specific IgE antibodies measured in the blood (Arasi et al., 2019). SPT and specific IgE 
results have been commonly dichotomized into positive or negative according to an 
arbitrary cut-off value. Typically, this was a 3mm wheal diameter for SPT and 0.35 
kU/l for specific IgE. Atopic manifestations may persist for several years and then 
resolve over time. However, in atopic children, adolescents and adults, allergy 
manifestations may evolve following a predetermined sequence, characterized by the 
progression from atopic dermatitis to allergic rhinitis and asthma (Arasi et al., 2019)  
 
Although several studies have examined the effect of allergens exposure indicating 
decline on various parameters of lung function in individuals with asthma, others 
showed that increased airway responsiveness is associated with an accelerated decline 
in lung function in individuals with no respiratory symptoms (Scichilone et al., 2005). 
Arasi and coauthors (2019) investigated the association between atopy, as determined 
by immediate cutaneous hypersensitivity to four common aeroallergens (house dust, 
ragweed, mixed trees, and mixed grasses), and the rate of decline of spirometric 
measurement of lung function, including FEV1 and FEV1/FVC ratio. They found that 
atopy was a significant independent factor of lung function decline among middle-aged 
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and older men without history of asthma. Lowe and colleagues (2004) found that 
children aged 3 years of age who were both sensitized and exposed to high levels of 
sensitizing allergen had significantly worst lung function compared with those who 
were either not sensitized or were sensitized but not currently exposed. These findings 
show that allergens might have an important role in lung function impairment, even if 
it is still uncertain whether they have an impact on lung function decline later in life. 
 
 
1.5.5. Preterm birth  
Preterm birth has been defined as any birth before 37 weeks of gestation. Rates of 
preterm birth have increased over the past 20 years, and 11% of all live births 
worldwide are estimated to be preterm (Townsi et al., 2018). As lung development is a 
process that is supposed to take place in utero, preterm born babies are at risk of later 
morbidity as lung development is interrupted during the canicular and saccular/ early 
alveolar phases.  
 
Various studies have investigated the short and long-term outcomes on lung function 
in survivors of preterm infants. A cohort of preterm born participants consisting of two 
population-based cohort was investigated by Vollsæter and colleagues (2013). The 
authors found that preterm infants, especially those with bronchopulmonary dysplasia 
(BPD), had significantly lower FEV1 and FEF25 than those born at term. Filippone and 
colleagues (2009) investigated lung function in preterm infants from age 5 to 15, 
showing lower lung function in 17 BPD survivors. Simpson and colleagues (2018) 
assessed longitudinal changes in lung function from early childhood to adulthood in 
very preterm babies (≤ 32 gestation weeks), showing that lung function trajectories in 
survivors of very preterm children were impaired, especially those with 
bronchopulmonary dysplasia and respiratory symptoms. In a cohort study assessing the 
lung function development of adolescence born preterm, Um-Bergström and 
colleagues (2017) suggested that subjects with a history of BPD preterm had a pattern 




Preterm birth is associated with increased respiratory symptoms, partially reversible 
airflow obstruction compared with those born at term (Forno et al., 2019). In a study 
of preterm babies, Narang and coworkers (Narang et al., 2008) reported that ex preterm 
infants had significantly greater respiratory symptoms compared with non-preterm 
infants. However, even if the prevalence of respiratory symptoms was still higher than 
in the control group, the prevalence was lower in adulthood than in mid-childhood for 
preterm babies.  
 
It is also widely recognized that male infants have a higher rate of respiratory disease 
than female infants. This is shown to be true even if they are term-born (Ito et al., 2017). 
Stocks et al (1997) showed that male sex was associated to lower lung function in 
healthy preterm born infants compared with healthy preterm-born female infants. 
Similarly, a study on extremely preterm babies (<28 weeks of gestation) found that 
male sex was associated to lower lung function at birth compared to females (Bentsen 
et al., 2017). Doyle and colleagues (2017) examined lung function in a preterm cohort, 
showing that extremely preterm born infants had small airway obstruction between 8 
and 18 years of age compared with controls, and that the airway obstruction increases 
with age. Thus, these findings suggest that preterm and very preterm babies are more 
susceptible to have lung function declined compared to those birth at term, and that 
impairment might persist into adulthood.  
 
 
1.5.6. Breastfeeding  
Breastfeeding has been associated with a variety of beneficial effect for children. 
Although various studies reported a protective association between breastfeeding and 
decline of lung function in children, this association remains uncertain (Oddy, 2017). 
A study conducted on the Isle of Wight cohort, Ogbuanu and colleagues (2009) found 
that children who were breastfed for at least 4 months had an increased FVC, FEV1 and 
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PEF (54 ml, 39.5 ml and 180.8 ml/s, respectively) compared with non-breastfed infants. 
A recent population-based cohort study including 4464 children have shown that a 
shorter duration of breastfeeding was associated with a lower FEV1 and FVC, while 
nonexclusive breastfeeding with a lower FVC in school-aged children (Meel et al., 
2020). However, not all studies have confirmed these associations. A prospective study 
including children from the ALSPAC cohort (Elliott et al., 2011) reported a modest 
protective effect of breastfeeding or wheezing in the first year of life. However, no 
effect of breastfeeding was seen on bronchial responsiveness. In a cohort of 377 healthy 
children, Gorlanova and coauthors (2020) found no significant association between the 
duration of breastfeeding and lung function outcome, or other respiratory symptoms in 
children. However, the authors reported that a longer duration of breastfeeding was 
associated with a reduced risk of atopic dermatitis in girls. The impact of breastfeeding 
on long term respiratory health has not largely investigated. In a study by Tennant and 
colleagues (2008) on 412 adults from the Newcastle Thousand Families cohort found 
that less than 4 weeks of breastfeeding was associated with lower adult FEV1. Although 
breastfeeding is shown to have beneficial impact on health, there is not clear evidence 




There is growing evidence that life events happening from in utero life, childhood 
through adolescence have an impact in increasing the risk of impaired lung function 
later in life. This in line with the Developmental Origins of Health and Disease 
(DOHaD) theory in which early-life exposures might have a long-term impact on 
disease in adulthood. It has been shown that that lung function tracks throughout 
adulthood, and longitudinal and cross-sectional studies link various prenatal and 
postnatal early-life predictors such as early life infections, asthma, and outdoor air 
pollution to a decline in lung function during childhood and adulthood. However, 
although a wide range of studies have reported changes in lung function over the life 
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course, it is still unclear if these are associated with a certain age range or if they have 
an impact on lung function trajectories.  
In this thesis, the main hypothesis is that early life exposure to lifestyle and 
environmental factors have a long-term impact on lung function trajectories. This 
hypothesis leads to the formulation of the general aim to investigate which early life 
predictors might contribute to be a risk to lung function impairment. The specific aims 
are described below: 
 
 
Aim 1.  Characterize lung function trajectories in the general population. 
It has been shown that based on life experiences, individuals in the general population 
have their own lung function trajectories that might already be defined in early life, 
when the lungs are still developing. However, it has been shown that pre- and post- 
natal life represent susceptible periods for each individual and identify which factors 
influenced belonging to a particular trajectory is important to implement strategy to 
prevent future health respiratory deficits. In this thesis I hypothesized that different 
lung function trajectories exist in the Raine study population. 
 
 
Aim 2. Identify early life, parental, and environmental predictors associated with 
low lung function trajectories identified. 
Although various early life predictors have been shown to be associated with low lung 
function in childhood, it is uncertain whether they have a long-term impact on lung 
function later in life, possibly leading to respiratory health impairments in adulthood. I 
hypothesized that childhood factors measured before the children were six years of age, 
and parental risk factors were associated with low lung function trajectories throughout 





Aim 3. Investigate the association between low air pollution concentration and 
lung function in children. 
Air pollution exposure increases the children mortality and morbidity, and it is an 
important cause of the global health disease. Children are considered a vulnerable 
group showing declined lung function when exposed to air pollution. Although the 
association between outdoor air pollution and lung function deficits has been largely 
investigated, less is known in areas at low concentrations level. I hypothesized that 
early-life exposure to outdoor air pollution, such as PM2.5 and NO2, would have a 








2.1. Introduction  
This Chapter presents the general methods used in the studies of my doctoral thesis. I 
have described the general methods used, including the description of the Raine Study 
population, the available data used, and the statistical analysis conducted. These 
methods are also partly covered in Chapters 3 and 4. 
 
 
2.2. Population study- The Raine Study 
Data used for this study are from the Raine Study. Between May 1989 and November 
1991, 2900 pregnant women were recruited from the public clinic at King Edward 
Memorial Hospital in Perth, Western Australia (Newnham et al., 1993). Extensive data 
was collected during pregnancy and the infants were assessed at birth.  The Raine Study 
established a set of core data which was then added to at each future follow up. The 
data included demographics and anthropometric measures on each participant, such as 
height, weight, and blood pressure to track them longitudinally over the life course. 
The families (parents) recruited for the study are known as Generation 1, while their 
children are known as Generation 2. As the follow-ups are still on-going, by 2016 some 
of the original Gen2 participants had become or were on the way to becoming parents 
themselves, so their children were invited to become part of the Raine Study, as 
Generation 3. A flow-chart of participants involved in the Raine Study is shown in 
Figure 2.1. From the first women enrolled in the study there were 2869 live births. 
Demographics, socioeconomic, and health behavior data were collected through 
questionnaires answered by the primary carers and children once old enough. Clinical 
and physical assessments were made at 18 and 34 weeks of gestation, birth and at ages 




For the purpose of this study, we used data from Generation2 participants retrieved by 
questionnaires and from clinical assessment. The variable used in this study are 
summarized in the next section.  
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2.3.  Variables and clinical outcomes 
2.3.1 Lung function - Spirometry  
Lung function was assessed at 6, 14, and 22 years of age by spirometry, following the 
American Thoracic Society guidelines in place at each time point (Crapo et al., 1995; 
Miller et al., 2005). FEV1 and FVC were measured from three forced expiratory curves 
with an acceptable start of test. The largest FEV1 and the largest FVC were recorded 
after examining the data from all acceptable curves. FEV1/FVC was calculated as the 
ratio of forced expiratory volume in the first one second to the forced vital capacity. 
Reference values were derived from the Global Lung Function Initiative (GLI) 
reference equations (Quanjer et al., 2012) that has been validated in a contemporary 
Australasian population (Hall et al., 2012). Using the GLI Tool Software developed by 
the GLI Task Force Group from the European Respiratory Society (ERS), we derived 
the z-scores for FEV1, FVC, and FEV1/FVC in participants that successfully completed 
and had acceptable and repeatable spirometry measurements.  
 
2.3.2. Questionnaire 
The respiratory questionnaire used were adapted from the International Study on 
Asthma and Allergies in Childhood (ISAAC) questionnaire for school children (Asher 
& Weiland, 1998) and applied in full at ages 6, 14 and 22.  In this thesis the following 
respiratory outcomes were determined, in line with previous Raine study publications 
(Hollams et al., 2009; Collins et al., 2011; White et al., 2017).  
 
Asthma 
- Current asthma was defined as a) having current wheeze in the past 12 months 
and b) having taken asthma medication in the past 12 months and c) ever having 
a doctor-diagnosis of asthma ever.  




We also classified asthma phenotypes as early-onset, persistent, and late-onset. Asthma 
phenotype was defined as: 
- Early-onset if asthma was present at six years of age only (i.e. not present after 
6 years of age). 
- Persistent if asthma was present from childhood up to adulthood 
- Late-onset if asthma occurred at 14 or 24 years of age, but not earlier 
   
Atopy 
Atopy was established by measurement of specific immunoglobulins (IgE) from serum 
sample and was defined as positive if the participants produced IgE antibodies in 
response to exposure to any of the following allergens: peanuts or food mix (food 
allergy); rye grass pollen, house dust mite, or mould (aeroallergens). 
 
Wheeze, Eczema and Hayfever 
- Wheeze was defined as a positive response to “Has you child wheezed in the 
last 12 months?”  
- Eczema was defined as a) a positive response to “Child has eczema?” and b) a 
self-reported doctor diagnosis ever 
- Hay fever was defined as a) a positive response to “Child has hay fever?” and 
b) a self-reported doctor diagnosis  
 
Respiratory tract infections 
Lower and upper respiratory tract infections were defined based on the illnesses 
reported by parents through the questionnaire. We converted the diseases into 
International Classification of Disease (ICD-9) codes, and we determine the health 
outcome if it was present during the first year of life.   
 
Maternal smoke  
Maternal smoke was defined as: 
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- in utero smoking if the mother has smoked only during pregnancy at 18 or 34 
weeks of gestation 
- Smoking at age six if the mother was smoking at the six year of follow up, but 
not in pregnancy 
- Smoking from pregnancy to age six if the mother has smoked during pregnancy 
and was still smoking at the six year follow up. 
 
Preterm birth 
Preterm birth was defined as any birth before 37 weeks of gestation. 
 
Socio-economic status 
Socio-economic status (SES) was defines based on family income per year expressed 
in Australian dollars ($AUD): a) less than 16.000 b) between 16.000 and 40.000 c) 
more than 40.000 
 
Demographics 
Demographics variables were retrieved from information provided by parents at 
baseline. Parental asthma, eczema, wheeze, and hay fever were defined if the mother 




Geocoding is the process of converting a description of a location, defined as 
coordinates, address, or a name of a place, to a location on the earth’s surface. The 
geocodes were provided by Dr David Blake and collaborators from the Edith Cowan 
University (ECU), in Perth using the home addresses provided by Raine participants 
during the years of follow-up from pregnancy to 22 years.  Data was processed using 





2.3.4 Air pollution data 
2.3.4.1. Air quality data 
Daily air pollution data across Perth were provided by the Department of Water and 
Environmental Regulation in Perth from 1991 to 2012 for PM2.5, PM2.5Absorbance, and 
NO2.   
Ambient air pollution concentrations in Perth were measured routinely at ten minutes 
intervals, for 24 hours, over one-year period, using Tapered Element Oscillating 
Microbalance (TEPM) method for PM2.5 and using Chemiluminescence method for 
NO2. The ten-minute interval data for each air monitor and year were compiled into 
specific-annual average of daily concentrations. Quality measurements across the area 
of Perth started in 1990 for NO2. However, more consistent continued NO2 and PM2.5 
measurements started in 1994. Among the fixed air monitoring stations operating in 
the metropolitan area, six sites (Caversham, Duncraig, Rockingham, South Lake, 
Swanbourne, and Quinns Rocks) recorded NO2 concentrations for more than 75% data 
over one-year period. Data for PM2.5 in the period between 1996 and 2003 were only 
available from two sites (Caversham and Duncraig), while data from 2004 to 2012 were 
available for four sites (Caversham, Duncraig, South Lake and Quinns Rocks).  
 
 
2.3.4.2 Estimation of air pollution exposure 
Land use regression (LUR) models for PM2.5, PM2.5Absorbance, and NO2 were developed 
in 2012 and validated by Dirgawati et al (2016) for the Perth Metropolitan area to 
estimate air pollutant concentrations across Perth. The modelling procedure was based 
following the procedures reported by the ESCAPE protocol 
(http://www.escapeproject.eu/). 
 
2.4. Statistical methods 
2.4.1. Air pollution exposure – Back-extrapolation of the air pollution data 
To estimate concentrations of air pollutions in the Raine participants we back-
extrapolated air pollution data, based on land use regression modeling developed in 
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2012 for the Perth Metropolitan area (Dirgawati, 2016). The air pollution trend can be 
estimated over a period longer than 10 years using LUR models. However, the 
reliability of the model depends on the characteristics of the area, whether there have 
been large changes in road network, emission sources and land use. Previous studies 
have back-extrapolated LUR models and reported good reliability on models even over 
a period of than 10 years (Levy et al, 2015).  
 
We back-extrapolated air pollution data using LUR models developed and validated 
for the Perth metropolitan area. We first estimated air pollution concentrations for the 
period in which PM2.5 and NO2 were measured from the fixed stations (1995-2012). 
Then, we applied the same standardized procedure to estimate NO2 and PM2.5Absorbance 
concentrations since 1990. Each participant’s exposure to PM2.5, PM2.5Absorbance and 
NO2 was estimated at pregnancy, birth and at 1, 2, 3, 5, 8, 10, 13, 16, and 22 years of 
follow-up and from the last residential address available, using geographical 
information system (GIS, version). We estimated the annual PM2.5, PM2.5Absorbance and 
NO2 average concentrations from the LUR model. Then, each participant’s exposure 
to PM2.5Absorbance and NO2 was estimated in early life when children were aged between 
3 and 4 years of age, using their exact date of birth and their year-specific address. 
Further details about the air pollution exposure in the Raine participants are given in 
Chapter 4.  
 
2.4.2. Group-based trajectory modelling (GBTM) 
To characterize lung function trajectories from 6 to 22-year follow-ups in the Gen2 
participants from the Raine Study, we used a finite mixture model through group-based 
trajectory modelling. Group based trajectory modelling (GBTM) is a statistical 
methodology for analyzing individual level-development trajectories, developed by 
Nagin (Nagin et al., 1999).  
 
The group-based trajectory model assumes that the population distribution of 
trajectories arises from a finite mixture of unknown order (Nagin et al, 2018).  
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Let Y1=  Yi1, Yi2, …Yit be a longitudinal sequence of measurements on individual i over 
length T periods and P(Yi) the probability of Yi given membership in group j and µi 
determines the probability of a randomly chosen population member belonging to 
group j. For individual i at a given age, the probability of Yi may be written as: 
𝑃(𝑌𝑖|𝐴𝑔𝑒𝑖) = ∑ µ




The conditional distribution of Yi given membership in j is indexed by the unknown 
parameter vector βj which among other parameters determines the shape of the group-
specific trajectory. This equation describes what is called a “finite mixture model”, 
because it sums across a finite number of discrete groups that comprise the population. 
For each individual within a given trajectory group j we assume that the distribution of 
yit (t=1,2,3...) is independent of the past period yit-1, yit-2, yit-3,… Thus, 
 






where 𝑝𝑗(𝑦𝑖𝑡|𝐴𝑔𝑒𝑖𝑡; 𝛽𝑗) is the probability distribution function of 𝑦𝑖𝑡 given 
membership in group j and the age of individual i at time T. 
The log- likelihood for the whole sample of N individuals is given by:  




The distribution 𝑝𝑗 is based on the type of data available for the analysis and can 
accommodate count data, where 𝑝𝑗 is assumed to follow a Poisson distribution or zero-
inflated Poisson distribution, binary data, where it is assumed to follow the binary logit 




The censored normal distribution is designed for the analysis of repeated data and it is 
the distribution used in this study. For the censored normal model, the linkage between 
age and the dependent variable is established by means of a latent variable yit
*j and 
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where 𝜀𝑖𝑡
 is an error term assumed to have a normal distribution with zero mean and a 
constant variance of 𝜎2. Where Smin and Smax, respectively, determines the minimum 
and maximum possible score on the measurement scale. The model assumes: 




𝑦𝑖𝑡 =  𝑦𝑖𝑡
∗𝑗
 𝑖𝑓 𝑆𝑚𝑖𝑛 ≤  𝑦𝑖𝑡
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Where the expected value of the latent variable 𝑦𝑖𝑡
∗𝑗  be 𝛽 
𝑗𝑥𝑖𝑡, a vector of length (n+1), 
and xit=(1, 𝑎𝑔𝑒𝑖𝑡 , 𝑎𝑔𝑒𝑖𝑡
2 … , 𝑎𝑔𝑒𝑖𝑡
2  . The log-likelihood equation becomes: 
 





























where Φ denotes the cumulative distribution, while 𝜙 denotes the density function. The 










here 𝜋?̂? is the estimated population in group j, while and ?̂?(𝑌𝑖|j) is the estimated 
probability of observing i trajectories of Yi given membership in j and is determined by 
using the maximum likelihood estimation.  
The model selection addresses two fundamental points: 1) the determination of the 
optimal number of groups 2) the determination of the shape of the trajectories, using 
the appropriate order of polynomial function for each group. The most common criteria 
used to determine the model fit include the Bayesian information criteria (BIC), Akaike 
information criteria (AIC), Lo-Mendell-Ruben likelihood ratio test (LMR-LRT), and 
entropy. Because comparison between models with k versus k+1 classes cannot be 
made via a standard likelihood comparison, BIC and AIC are commonly used to 
evaluate model fit by balancing model complexity. These standard procedures 
described above have been used in this thesis to characterize lung function trajectories 
from childhood to adulthood in the Raine participants. To evaluate the most appropriate 
model, different models with different polynomial functions and with the same number 
of trajectories, were compared. Then, the best model with J trajectories was compared 
with a model with J+1 trajectories. After identifying the number of groups and the 
different shapes of the trajectories, model adequacy was tested using the average 
posterior probabilities (APP) of group membership, that Nagin (2005) recommends 
should exceed 0.70 for each group. An average posterior probability above 0.70 






Data from the Raine Study were used to characterize lung function trajectories from 6 
to 22 years of age in Generation2 participants and to investigate which early-life risk 
factors are associated with the low lung function trajectories identified. Among other 
early risk factors, we estimated air pollution data as NO2, PM2,5 and PM2,5Absorbance in 
the participants when they were aged six. For this purpose, we back-extrapolated air 
pollution data from LUR models developed in 2012 for the Perth Metropolitan area. 





Characterization of lung function trajectory through group-
based trajectory modelling 
 
3.1 Introduction 
Lung function is a well-recognized marker of respiratory health, the most commonly reported 
outcomes being from spirometry, FEV1, FVC and FEV1/FVC. Lung function is characterized by 
three phases of development through the life course. In the first phase lung function increases as 
the lungs grow, reaching a peak in women at around 18 and in men at about 20 years of age 
(Karmaus et al., 2019). The second phase is a plateau phase enduring till early adulthood, followed 
by a decline due to physiological ageing (Agusti & Faner, 2019). A trajectory describes the course 
of a variable over age or time, as shown in Figure 3.1.  
 
 
Figure 3.1. Potential lung function trajectories in childhood, puberty into adulthood 
 
     Agusti et al., 2019 
Note* The normal lung function trajectory can be divided in three phases of development from childhood to adulthood, 
followed by lung function decline due to ageing. Various factors might modify the path of the trajectories over life.  
55 
 
Birth-cohort studies have shown that there is a distribution of lung function trajectories in the 
population. Bui et al (2018) identified six trajectories of lung function from 7 to 53 years of age, 
using the Tasmanian Longitudinal Health Study (TAHS). Another study (Belgrave et al., 2014) 
identified three trajectories from early school age into early adulthood using two population-based 
birth cohorts: the Manchester Asthma and Allergy Study (MAAS) and the Avon Longitudinal 
Study of Parents and Children (ALSPAC). Berry et colleagues (2016), using data from the Tucson 
Children’s Respiratory Study (CRS) found two lung function trajectories, a low and a normal  
trajectory from 11 to 32 years of age.  
 
Various statistical methods, such as hierarchical or latent curve modeling, have been used for 
analyzing not only developmental trajectories, but also which predictors may affect their shape. 
They estimate the population average trajectory and use predictors to investigate these 
associations. Recent advances in statistical modelling and their application to clinical research uses 
group-based trajectory modelling [Fan & Zhang, 2020; Jeon, Jung & Jee, 2019; Bui et al, 2018 ]. 
Unlike the other models, it assumes that the population consists of distinct groups with different 
trajectories (Nagin & Odgers, 2010). Group-based trajectory modelling (GBTM) was firstly 
reported by Nagin and Land (1993) and has been increasingly applied in clinical research (Nagin 
& Odgers, 2010), including respiratory health (Bui, 2018). Trajectory models have been used to 
understand the etiology and the development course of various diseases, such as obesity (Fan & 
Zhang, 2020) and diabetes (Jeon, Jung & Jee, 2019). 
 
The aim of the group-based trajectory model is to identify complex patterns in longitudinal 
analysis, as well as identify clusters of individuals with similar trajectories. This approach 
identifies individuals that follow similar development of a variable over time and estimates the 
effect of predictors on different trajectories identified. This method may be preferable over other 
approaches such as hierarchical and latent curve modeling when handling trajectories that do not 
vary regularly in the population. It has been shown that based on early- life exposures, individuals 
in the general population have their own lung function trajectories that might be already defined 
in early life, when the lungs are still developing. Pre- and post-natal life represents susceptible 
periods for each individual and identify which factors influenced the belonging to a particular 
trajectory is important to implement strategy to prevent future health respiratory deficits.  
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In this thesis it is hypothesized that different lung function trajectories exist in the Raine Study 
population. 
 
In the Chapter I have provided the procedure of the group-based statistical modelling used for 
characterizing lung function trajectories, as we hypothesized that insults in early life are associated 
with low lung function trajectories. Specifically, I have described the procedure I have applied to 
identify lung function trajectories from 6 to 22 year of follow ups in the Raine Study participants. 
The results from this study are reported in Chapter 5, in which I will investigate which early-life 
factors are associated with the identified lung function trajectories. 
 
3.2. Methods 
3.2.1. Study population 
Raine participants attending at least two visit that included the spirometry measurement within the 
6, 14 or 22 years of follow-up were included in this study.  The FEV1, FVC, and FEV1/FVC (z-
scores) individual measures of spirometry were derived from the Global Lung Initiative reference 
equations (Quanjer et al., 2012), validated in the Australian population (Hall et al., 2012). 
 
 
3.2.2. Statistical analysis 
3.2.2.1. Group based trajectory modelling  
Group based trajectory modelling was used to identify trajectories of lung function from 6 to 22 
years in the Raine participants. Modelling was performed using the STATA (version 16.0; 
StataCorp, College Station, TX) “traj” plugin (Jones & Nagin, 2013). A censored normal model 
was fitted to the data because the FEV1 and FVC values (z-scores) were continuous. The shape of 
the trajectories was defined by a polynomial function of age, that can be modeled with up to a 
fifth-order polynomial function. We determined the optimal number and shape of lung function 
trajectories based on the smallest absolute Bayesian Information Criterion (BIC) value and average 
posterior probabilities. We considered an average posterior probability of >0.7 as an indicator of 
good model fit, as indicated in the Nagin recommendations (Nagin & Odgers, 2010). We first 
started with a model that consisted of one group with the highest polynomial order (cubic), and 
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then we increased the groups until the number of groups that best fitted the data was identified 
(Peristera et al., 2020). Once the number of trajectories was identified, we reduced the polynomial 
orders until the highest order polynomial for each group was significant at the confidence level 
alpha (x)= 0.05. After selecting the best fitting model, participants were automatically assigned to 
one of the groups based on their highest estimated group membership probabilities, that is the 
probabilities of each participant’s belonging to each of the trajectory groups.  This results in a 
distribution over classes. We modelled trajectories for FEV1, FVC and FEV1/FVC separately. 
Sensitivity analysis were conducted to test the reliability of trajectories identified. We performed 




To characterize the lung function trajectories, we included data from 1512 children in the cohort 
(768 males and 744 females, mean age at baseline 5.9 SD± 0.2 years). All included participants 
had at least two valid spirometry measurements of FEV1 and FVC with spirometry performed 
between 6 and 22 years (Figure 3.2). Characteristics of children are shown in Table 3.1. Boys had 
a higher proportion of childhood asthma (p=0.03) and allergies in childhood (p<0.001), while 
wheezing and eczema in young adulthood were more prevalent in females (p=0.03 and p=0.001, 
respectively). Late-onset asthma was prevalent in females (p<0.001). Compared with the 1512 
included participants, excluded participants had lower SES, less respiratory tract infections, 
childhood and parental hay-fever, asthma, atopy, and more of them were born preterm or had 






























Table 3.1. Childhood and parenthood characteristics in participants with two or more spirometry measurements 
according to sex. 
Participant demographics (n=1512) 
Variable Male Female P-value 
Gender, % 768 (50.79) 744 (49.21)  
Socioeconomic status   0.713 
≤16.000  67 (9.45) 70 (10.14)  
16000-40000 316 (44.57) 293 (42.46)  
≥40000   326 (45.98) 327 (47.39)  
Respiratory infections, %    0.879 






n= 2900 pregnancy women recruited 
from the public clinic at King 
Edward Memorial Hospital in Perth, 
Western Australia  
n=2868 live births 
n=1512 lung function trajectories 
of FEV1, FVC and FEV1/FVC 
 
 
with at least one FEV1 and FVC 
spirometry measurement at age 6,14, and 





with at least two spirometry 
measurement of FEV1 and FVC at age 

















URTI only 245 (35.61) 244 (36.31)  
LRTI or both 182 (26.45) 182 (27.08)  
Preterm (<37 gestational age), 45 (6.09) 56 (7.94) 0.167 
Asthma phenotypes    0.007 
Early-onset asthma 75 (10.37) 57 (8.01)  
Persistent  13 (1.80) 10 (1.40)  
Late-onset 38 (5.26) 69 (9.69)  
Current asthma at age 6, % 133 (17.32) 99 (13.31) 0.030 
Current asthma at age 14, % 78 (10.16) 69 (9.27) 0.563 
Current asthma at age 22, % 40 (5.21) 63 (8.47) 0.012 
Current wheeze at age 6, % 172 (23.40) 142 (20.03) 0.120 
Current wheeze at age 14, % 98 (13.78) 94 (13.49) 0.871 
Current wheeze at age 22, % 84 (17.54) 118 (22.96) 0.034 
Current eczema at age 6, % 166 (22.90) 174 (24.96) 0.361 
Current eczema at age 14, % 127 (17.81) 147 (21.06) 0.123 
Current eczema at age 22, % 45 (9.53) 82 (16.43) 0.001 
Current hay fever at age 6, % 51 (6.64) 53 (7.12) 0.711 
Current hay fever at age 14, % 156 (21.88) 135 (19.37) 0.244 
Current hay fever at age 22, % 73 (15.37) 104 (20.47) 0.037 
Atopy, %   <0.001 
Food Allergy only 44 (5.73) 52 (6.99)  
Aeroallergens only 65 (8.46) 41 (5.51)  
Both  273 (35.55) 184 (24.73)  
Maternal smoking   0.287 
Only in pregnancy 31 (4.41) 35 (5.21)  
Only at age 6 52 (7.41) 54 (8.04)  
Both in pregnancy and at age 6 130 (18.49) 147 (21.88)  
Parental Asthma, %   0.268 
Mother only 111 (16.82)  104 (16.48)  
Father only 53 (8.03) 71 (11.25)  
Both 18 (2.73) 18 (2.85)  
Parental Eczema, %   0.445 
Mother only 117 (17.67) 106 (16.80)  
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Father only 42 (6.34) 55 (8.72)  
Both 21 (3.17) 19 (3.01)  
Parental Hay fever, %   0.481 
Mother only 231 (30.08) 210 (28.23)  
Father only 123 (16.02) 116 (15.59)  
Both 97 (12.63)   114 (15.32)  
Parental Wheeze, % 313 (43.05) 313 (44.78) 0.512 
*SES=socio economic status was defined by the family incomes, expressed in Australian dollars ($AUD), LRTI= low 
respiratory tract infections in the first year of life, URTI= upper respiratory tract infections in the first year of life. 
**Full details of the variable definitions are reported in the Chapter 2. 
 
 
3.3.1. Lung function trajectories 
We fitted individual models to analyze the lung function trajectories of FEV1, FVC, and FEV1/FVC 
(z-scores). Longitudinal modeling identified four lung function trajectories for FEV1 (Figure 3.3), 
FVC (Figure 3.4) and FEV1/FVC (Figure 3.5), that best fitted our data with a membership 
probability of >0.7 for each group. The best fitted models are reported in Supplementary Tables 
3.2 A, B and C, while the average posterior probabilities for each group within the lung function 
parameters are reported in the Supplementary Table 3.3. FEV1 and FVC were characterized by 
four trajectories that we have called respectively: “very low”, “low”, “average” and “above 
average”. FEV1/FVC was also characterized by four trajectories based on their shapes, these are: 
“very low”, “low-high”, “high-low” and “average” trajectories. The distribution of FEV1, FVC 
and FEV1/FVC in the lung function trajectories of the Raine participants with two or more 
spirometry measurements are described in Table 3.2, showing that most of participants were in the 
low and average of FEV1 and FVC trajectories, while in the average and high-low trajectories for 
FEV1/FVC. We also assessed the overlap of participants both in FEV1 and FVC lung function 







Figure 3.3. Lung function trajectories (FEV1) from 6 to 22 years of follow up in the Raine participants with two or 
more spirometry measurements 
 
 

















Figure 3.4. Lung function trajectories (FVC) from 6 to 22 years of follow up in the Raine participants two one or 









Figure 3.5. Lung function trajectories (FEV1/FVC) from 6 to 22 years of follow up in the Raine participants two or 
more spirometry measurements
 
Note* The 95% confidence intervals are represented by dashed lines   
 
 
As the trajectories of FEV1/FVC were not what we expected, showing either decline or growth 
between 6 and 14 years of age, we investigated its reliability as shown in Supplementary Figure 1 
and Supplementary Table 3.4. We investigated whether the membership to trajectories for 
participants with two or more spirometry measurements at any age was different to those with 
spirometry at both 14 and 22 years. Trajectory membership was unchanged, with most of the 





Table 3.2 Distribution of forced expiratory flow in one second (FEV1), forced vital capacity (FVC) and their ratio (FEV1/FVC) in the lung function trajectories in 
the Raine Study participants with two or more spirometry measurements. 












































Total 1512  1512 1512 














Table 3.3  Individual distribution of FEV1 and FVC lung function trajectories in the Raine Study participants with 
two or more spirometry measurements. 














Note. *All values are given as frequencies with percentages in parentheses. 
 FVC  

















































Total 61 456 139 856 1,512 
66 
 
 3.4. Conclusions 
In this study we characterized lung function trajectories using spirometry measurements at age six, 
14 and 22 years from the Raine Study cohort. By using a finite mixture model through group-based 
trajectory modelling, we identified four trajectories for FEV1, FVC and FEV1/FVC. Lung function 
trajectories for FEV1 and FVC were similar in shapes, being characterized by a very low, low, 
average, and above average trajectories, where the low trajectory was the most populated 
trajectory. FEV1/FVC was characterized by a very-low, low-high, average, and high-low 
trajectories, based on their shape, where nearly half of participants were in the average trajectory.  
To date, few studies have investigated lung function trajectories over time. The Tucson’s Children 
Respiratory Study (CRS) identified lung function trajectories in 599 individuals aged between 11 
and 32 years, identifying a persistently low trajectory and a normal trajectory for FEV1/FVC (Berry 
et al., 2016). Karmaus and colleagues (2019) studied lung function trajectories in 1158 participants 
from 10 to 26 years in males and females, separately. They identified two trajectories for FEV1, 
FVC and FEV1/FVC, and three trajectories for FEF25-75. In the CAMP Study, 684 individuals with 
asthma were followed from 23 to 30 years of age and four trajectories of FEV1 were identified 
within the group (McGeachie et al., 2016). In the Manchester Asthma and Allergy Study, Belgrave 
and colleagues (2014) identified three trajectory of lung function in 1,051 individuals for male and 
female, separately, using specific airway resistance measurements from 3 to 11 years of age. The 
study with the largest age range was conducted by Bui et al (2018) using the Tasmanian 
Longitudinal Health Study (TAHS) and they analyzed lung function trajectories in individuals 
followed from 5 to 53 years of age. They identified six paths, of which two (the early below 
average, accelerate decline and early low, accelerate growth, normal decline) were new compared 
with previous studies. Even if lung function trajectories have been subject of few studies, to the 
best of our best knowledge, none has examined trajectories of FEV1, FVC and FEV1/FVC from 
childhood to adulthood in a large study population and expressed these as z-scores, hypothesized 
to be the most clinical meaningful approach (Vaz Fragoso et al., 2016). Differently from our study, 
Bui et al found six trajectories of FEV1. This can be due to the fact that the participants involved 
in the TAHS were older compared with those in our study and thus we could not detect lung 





One strength of our study is the large sample of children and a long period of follow-up which 
covers developmental periods from childhood to adolescence and the adulthood, with available 
measurements over the years. This allowed us to established lung function trajectories over sixteen 
years from early life to young adulthood. This study has some limitations. Although spirometry is 
considered to be reliable and acceptable in pre-school children, one of the limits encountered when 
performing spirometry is that patients might be unable to exhale completely. Indeed, a limitation 
of the study is that in our population sample, the forced vital capacity measured at six years may 
be underestimated, and therefore potentially resulting in an overestimation of lung function 
trajectories of FEV1/FVC ratio. However, in a sensitivity analysis, when we included participants 
with spirometry measurement at 14 and 22 years of age (might have also 5), the ratio FEV1/FVC 
still resulted in four trajectories with the same shapes, suggesting that misrepresentation of FEV 
or FVC at five to six years of age was unlikely to have contributed to inappropriate trajectories in 
FEV1/FVC.   
Thus, group-based trajectory modelling has been found to be a reliable statistical model that can 
be applied in the respiratory context, and we identified groups of individuals in the population that 
follow similar lung function trajectories over time. This finding suggested that lung function 
trajectories are established before six years of age. The lung function trajectories identified would 
serve as a basis to identify which are the early-life factors associated with low lung function 












3.5. Supplementary material  







Female Gender, % 744 (49.21) 670 (49.41) 0.913 
Socioeconomic status   <0.001 
≤16.000  137 (9.79) 95 (13.46)  
16000-40000 609 (43.53) 359 (50.85)  
≥40000 653 (46.68) 252 (35.69)  
Respiratory infections, %    <0.001 
URTI only   503 (33.27) 346 (25.52)  
LRTI or both 333 (33.27) 227 (16.74)  
Preterm (<37 gestational age), % 101 (6.99) 117 (9.07) 0.046 
Asthma phenotypes    <0.001 
Early-onset asthma 135 (9.41) 90 (6.75)  
Persistent  22 (1.53) 1 (0.08)  
Late-onset 107 (7.46) 41 (3.08)  
Current asthma at age 6, % 235 (15.54) 114 (8.41) <0.001 
Current asthma at age 14, % 147 (9.72) 49 (3.61) <0.001 
Current asthma at age 22, % 103 (6.81) 18 (1.33) <0.001 
Current wheeze at age 6, % 314 (21.75) 168 (22.70) 0.610 
Current wheeze at age 14, % 192 (13.64) 61 (15.72) 0.296 
Current wheeze at age 22, % 202 (20.34) 28 (18.42) 0.582 
Current eczema at age 6, % 340 (23.91) 155 (21.03) 0.131 
Current eczema at age 14, % 274 (19.42) 64 (16.49) 0.192 
Current eczema at age 22, % 127 (13.08) 24 (16.11) 0.314 
Current hay fever at age 6, % 104 (6.88) 50 (3.69) <0.001 
Current hay fever at age 14, % 291 (20.64) 66 (17.01) 0.113 
Current hay fever at age 22, %   177 (18.01) 26 (17.22) 0.814 
Atopy, %   <0.001 
Food Allergy only 96 (6.35) 28 (2.06)  
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Aeroallergens only 106 (7.01)   29 (2.14)  
Both  457 (30.22) 124 (9.14)  
Current FEV1 at age 6, (z-scores) -0.85 (0.98) -0.89 (0.99) 0.261 
Current FEV1 at age 14, (z-scores) -0.46 (1.04) -0.63 (1.07) 0.024 
Current FEV1 at age 22, (z-scores) -0.11 (0.99) -0.29 (1.07) 0.071 
Current FVC at age 6, (z-scores) -1.08 (1.05) -1.04 (1.31) 0.753 
Current FVC at age 14, (z-scores) -0.79 (1.06) -0.87 (1.01) 0.181 
Current FVC at age 22, (z-scores) 0.08 (0.93) -0.02 (0.82) 0.189 
Current FEV1/FVC at age 6, (z-scores) 0.71 (1.18) 0.66 (1.26) 0.263 
Current FEV1/FVC at age 14, (z-scores) 0.71 (1.19) 0.52 (1.32) 0.030 
Current FEV1/FVC at age 22, (z-scores) -0.34 (0.92) -0.50 (1.03) 0.078 
Maternal smoking   0.003 
Only in pregnancy 66 (4.80) 45 (6.34)  
Only at age 6 106 (7.71) 62 (8.73)  
Both in pregnancy and at age 6 277 (20.15) 183 (25.77)  
Parental Asthma, %   0.291 
Mother only 215 (16.65) 88 (13.97)  
Father only 124 (9.60) 55 (8.73)  
Both 36 (2.79) 23 (3.65)  
Parental Eczema, %   0.701 
Mother only 223 (17.25) 118 (18.47)  
Father only 97 (7.50) 44 (6.89)  
Both 40 (3.09) 15 (2.35)  
Parental Hay fever, %   <0.001 
Mother only 441 (29.17) 207 (15.27)  
Father only 239 (15.81) 122 (9.00)  
Both 21 (13.96) 77 (5.68)  
Parental Wheeze, % 626 (43.90) 307 (41.60) 0.306 
*Values are means (SD) or percentages (absolute numbers). Differences were tested by using the Student t test for 
continuous variables, and the X2 test for categorical variables. **SES=socio economic status was defined by the 
family incomes, expressed in Australian dollars ($AUD), LRTI= low respiratory tract infections in the first year of 
life, URTI= upper respiratory tract infections in the first year of life. ***Full details of the variable definitions are 
reported in the Chapter 2. 
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Supplementary Table 3.2. Model selection for FEV1, FVC and FEV1/FVC 
FEV1 
Polynomial BIC AIC 
3 -5371.13 -5357.83 
3 3 -5094.61 -5068.01 
3 3 3  -5028.05 -4988.14 
3 3 3 3  -4996.05 -4942.84 
1 3 3 3  -4990.38 -4942.49 














Note* The number of trajectory groups is represented by the number of polynomials with the corresponding type: 
1=linear, 2=quadratic, 3=cubic
FVC 
Polynomial BIC AIC 
3 -5432.57 -5419.27 
3 3 -5222.18 -5195.58 
3 3 3  -5190.94 -5151.03 
3 3 3 3 -5190.93 -5137.72 
1 1 2 3  -5190.65 -5153.74 
3 3 3 3 3  -5201.39 -5134.87 
FEV1/FVC 
Polynomial BIC AIC 
3 -5778.60 -5765.30 
3 3 -5663.34 -5636.74 
3 3 3  -5566.71 -5526.80 
3 3 3 3  -5471.34 -5431.43 
1 3 3 3  -5469.26 -5421.37 




Supplementary Table 3.3. Average posterior probabilities for each group within FEV1, FVC, and FEV1/FVC trajectories. 






 Trajectories Trajectories Trajectories 
 Very 
Low 



















Supplementary Table 3.4. FEV1/FVC trajectories in participants with spirometry measurements at age 14 and age 22 (might also have spirometry measurements 
at age 6) (n=869) 
 
Note* The 95% confidence intervals are represented by dashed lines  
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Supplementary Table 3.5. Individual distribution of FEV1/FVC lung function trajectories in the Raine 
Study participants with two or more spirometry measurements and spirometry measurements at 14 and 
22 years of age. 
 Two or more spirometry measurements   
14 & 23 spiro  
(might have also at age 5) 
 
Low Low-high High-low Average Total 
Low 74  5   
Low-High  100  6  
High-Low  1 311 37  
Average    335  
Total     869 
 
Note* n=1512 participants had two or more spirometry measurements between 6, 14 and 22 years of 















Environmental air pollution is a major health problem affecting everyone in low, middle, and high-
income countries (Tong, 2019). In utero and early-life environmental air pollution exposure may 
affect optimal lung development and promote respiratory deficit during childhood that tracks into 
adulthood (Kim et al., 2018). Cross-sectional and longitudinal studies (Götschi et al., 2008; Mölter 
et al., 2013; Gehring et al., 2013) have reported declining lung function in children with a short 
and long-term exposure to air pollution, such as particulate matter (PM), and nitrogen dioxide 
(NO2), as well as PM25Absorbance that is a marker for black carbon. However, the findings are 
controversial. Some studies showed associations with FEV1 or FVC, others with both lung volume 
and expiratory flow, while some studies did not find any association at all. Although some 
researchers have shown that in utero and exposure in early life were associated with respiratory 
diseases, the long-term consequences of early-life exposure to air pollution on lung function are 
poorly understood.  
 
Land Use Regression models are increasingly being used to estimate exposure to ambient air 
pollution for current or recent periods in which direct measurements of air pollution are available. 
In these models, data are usually collected during a dedicated environmental sampling periods at 
a defined number of monitoring stations, with the aim to develop a prediction model using 
characteristic variables, such as land use, traffic, and physical environment. Most of the existing 
LUR models have been used for the prediction of air pollutants in Western Europe and North 
America (Hoek et al., 2008; Jedynska et al., 2014; Eeftens et al., 2012) and none was available for 
Western Australia, since Dirgawati and colleagues (2016) developed and validated LUR models 
in 2012 for the Metropolitan Area of Perth. Despite their advantage in being easily applicable by 
researchers, LUR have some limitations. In fact, they require availability of a large number of 
monitoring sites, that together with a high number of variables can otherwise increase the risk of 
“overfitting” LUR models. Further, land use regression models require availability of accurate 
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historical air pollution measurements when transferring current or recent LUR models to earlier 
years, via back-extrapolation. 
 
A method for the back-extrapolation of NO2, NOx, PM2.5, PM10, PM2.5Absorbance and PMcoarse 
estimated concentrations has been proposed by the European Study of Cohort for Air Pollution 
Effects (ESCAPE) project (www.escapeproject.eu). This approach estimates air pollution 
concentrations at historical addresses using historical air pollution measurements usually derived 
from the national monitoring network. The estimates are then assigned as individual exposure for 
the cohort participants in order to investigate the association between exposures and a particular 
health outcome. Previous studies have proven that the correlation between air pollution 
concentration of different years is high, even over a period of more than 35 years (Gulliver, 2013), 
but there are often insufficient and low reliable available data of past measurements, thus the back-
extrapolation of LUR models might represent a challenging task (Levy et al., 2015). Further, 
whether a trend can be estimated over a time longer than 10 years is area-specific and depends on 
whether there have been large changes in road network, emission sources, or land use (ESCAPE 
manual) 
 
The aim of this study was to conduct the back-extrapolation of the LUR models developed in 2012 
for the Metropolitan area of Perth and estimate historical concentrations of NO2, PM2.5, and 
PM2.5Absorbance for earlier years, assigning individual air pollution exposure at residential addresses 
in the Raine participants from three to 22 years of age. 
 
In this Chapter, I defined individual exposure to main air pollutants in the Raine participants from 
childhood to young adulthood, using a preexisting and validated Land Use Regression model. The 
results from this study will be applied in Chapter 5, where air pollution exposure in early life serve 
as predictors for the lung function trajectories identified in Chapter 3. 
 
4.2. Methods 
4.2.1. Area of study and population study 
The study area consists of the Perth Metropolitan Region, capital of Western Australia, that 
extends in 6,418 km2 with more than 2 million inhabitants in 2019. The city is characterized by an 
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Australian climate with a hot and dry summer, and a rainy season occurring between May and 
October (Nguyen et al., 2020).  The participants included in this study were participants from the 
Raine Study with residential address history in early life between three and five years of age (1993-
1995) (Figure 4.1) 
 
4.2.2 Air quality data 
Daily air pollution data across Perth were provided by the Department of Water and Environmental 
Regulation in Perth from 1991 to 2012 for PM2.5, PM2.5Absorbance, and NO2, that operates air quality 
monitoring network in Perth (Supplementary Table 4.1, 4.2) 
 
4.2.2.1 Back-extrapolation air pollution data 
We back-extrapolated air pollution data using LUR models that were carried out and validated for 
the Perth metropolitan area in 2012 (Dirgawati et al., 2016). We first estimated annual air pollution 
concentrations for the period in which PM2.5, PM2.5Absorbance and NO2 were measured from the fixed 
stations between 1995 and 2012. Then, we applied the same standardized procedure to estimate 
NO2 and PM2.5Abs from 1991 to 2012 as the historical measurements of these pollutants started 
earlier in time.  
 
Following the Escape guidelines (http://www.escapeproject.eu) we back- extrapolated LUR-based 
predicted concentration of PM2.5 and NO2 by using 1) the predicted annual average concentrations 
from LUR models for the year 2012, and 2) the annual average of measured concentrations from 
the eligible air monitoring stations that covered the year preceding the baseline period of our study 
(1994), baseline period of our study (1995), the years of follow-up until the LUR model 
development (2012). The annual concentrations for the whole period between 1994 and 2012 were 
averaged. This provided annual average background concentrations for the entire Perth 
metropolitan area and for each predicted year from 1995 to 2012 (C-routine). We calculated for 
each study participant the average concentration based on the year before and the year after the 
age six for the baseline date for the routine monitoring site (C-routine baseline). A correction factor 
(Ratio) between the average one year before and one year after the baseline date and the year of 
2012 when LUR models was developed. The back-extrapolated concentrations for each current 
residential address and each predict year (C-extrapolated) was calculated by multiplying the LUR-
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based predicted annual average specific-year concentration for each home address with the 
corresponding year-specific correction factor.  
 
 
𝐶𝑟𝑜𝑢𝑡𝑖𝑛𝑒−𝑏𝑎𝑠𝑒𝑙𝑖𝑛𝑒 = 𝑏𝑎𝑠𝑒𝑙𝑖𝑛𝑒 𝑑𝑎𝑡𝑒 +/−1 𝑦𝑒𝑎𝑟 
 
𝑅𝑎𝑡𝑖𝑜 =  𝐶𝑟𝑜𝑢𝑡𝑖𝑛𝑒−𝑏𝑎𝑠𝑒𝑙𝑖𝑛𝑒/𝐶𝑟𝑜𝑢𝑡𝑖𝑛𝑒−𝐸𝑠𝑐𝑎𝑝𝑒  
 
𝐶𝑒𝑥𝑡𝑟𝑎𝑝𝑜𝑙𝑎𝑡𝑒𝑑=𝐶𝐸𝑠𝑐𝑎𝑝𝑒 ∗ 𝑅𝑎𝑡𝑖𝑜 
 
 
As fixed air monitoring stations data were not available for PM2.5Absorbance, temporal NO2 
concentrations were used as a proxy for temporal change in PM2.5Absorbance concentrations.  All 
statistical analysis was performed with STATA (version 16.0; StataCorp, College Station, TX). 
 
Each participant’s exposure to PM2.5, PM2.5Absorbance and NO2 was estimated at pregnancy, birth 
and at 1, 2, 3, 5, 8, 10, 13, 16, and 22 years of follow-up on the basis of the last residential address 
available, using geographical information system (GIS, version). We estimated the annual PM2.5, 
PM2.5Absorbance and NO2 average concentrations from the LUR model as previously described. Then, 
each participant’s exposure to PM2.5Absobance and NO2 was estimated in early life when children 
were aged between 3 and 4 years of age, using their exact date of birth and their year-specific 
address. 
     
 
4.3. Results 
Out of the 2,370 participants included in this study, 1329 did not move between three and five 
years of age, while 804 did not move between the gestational period of the mother and three 
























4.3.1. Individual air pollution exposure in the Raine participants 
Based on LUR model developed for the Perth Metropolitan Area, we estimated exposure to air 
pollutants at geocodes based on each participant’s home street address. Annual average 
concentrations of PM2.5, PM2.5Abs and NO2 from 1995 to 2012 in the Raine participants are shown 
in Figure 4.2 A, B and C. Due to the availability of two monitoring sites for NO2 across Perth 
(Caversham and Perth CBD) earlier then 1995, we back-extrapolated data and estimate individual 









n= 2900 pregnancy women recruited 
from the public clinic at King 
Edward Memorial Hospital in Perth, 
Western Australia  
n=2868 live births 
with residential history 




 N= 804 no-movers between pregnancy 
and 3 years of age 
N=1329 no movers between 3 and 5 














Figure 4.2 A, B, C. Annual average concentration of PM2.5, Pm2.5Absorbance, and NO2 in the Raine participants 














































In 1995, the annual mean concentration in the Raine participants was 6.28 µg/m3 (SD± 1.89) for 
Pm2.5, 0.86 ·10
-5 m-1 (SD ± 0.33) for Pm2.5Abs and 4.37 µg/m
3 (SD ± 2.17) for NO2 (Table 4.1 A, B, 
C). Early-life exposure to air pollutants when children were aged between three and four years of 
age was calculated for NO2 and PM2.5Abs as the historical data for these pollutants started earlier 
than PM2.5. The average concentrations of PM2.5Absorbance and NO2 at home address for the first year 
of life and the lifetime average concentrations from the first year of life to 22 years (1991-2012) 
are presented in Supplementary Table 4.3 A, B. The spatial distribution of annual average 
concentration of NO2, PM2.5 and PM2.5Absorbance in 1995 are shown in Supplementary Figures 4.2, 
4.3 and 4.4. The central busines district (CBD) is the area in which the concentrations were higher 
for all the three air pollutants across the Metropolitan area of Perth, while the surrounding areas 




Table 4.1 A, B, C. Descriptive summary of PM2.5. PM2.5Absorbance and NO2 at baseline and during the years of follow-





















4.4. Discussion  
Together with other risk factors, environmental exposure to air pollution might lead to lung 
function deficits that may track into adulthood (Kim et al., 2018). Although the association 
between early life exposure of air pollution and declined lung function has been reported, findings 
are controversial and respiratory outcomes later in life might vary for different pollutants. In 
addition, a wide range of studies demonstrated the linked between the adverse effects of air 
pollution on lung function cross-sectionally, while less is known about the long-term consequences 






1995 6.28 ±1.82 0.06 10.70 
During the years of 
follow up (1995-2012) 








1.00 ±0.38 0.02 2.99 
1995 0.86 ±0.30 0.04 2.29 
During the years of 
follow up (1995-2012) 




Std Dev Min Max 
Early-life 
(3.5- 4.5 years) 
5.20 ±2.08 0.11 12.19 
1995 4.38 ±1.65 0.08 10.37 
During the years of 
follow up (1995-2012) 
3.86  ±1.34 0.27 9.70 
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pollution endures into young adulthood is still unknown. In this study we estimated historical air 
pollution exposure for 2,370 Raine Study participants, from early-life to young adulthood. By 
using land use regression models developed for the Metropolitan Area of Perth in 2012, we back-
extrapolated data back in time for PM2.5, PM2.5Absorbance and NO2.  
 
The air pollution exposure models were modelled based on monitoring stations across the 
metropolitan area of Perth in 2012 and were used to estimate exposures in early life between 1993 
and 1995. Currently, individual exposure estimates often assume that the concentrations estimated 
from the LUR model are valid for long period of time, and few studies have proven the stability 
of land use regression models, even over a period of more than 35 years (Beelen et al., 2007; 
Gulliver, 2013). In a study conducted in the Netherlands, Eeftens and colleagues (2011) compared 
two set of NO2 measurements at the same location to test the stability over time, and they found 
good agreement between measured spatial contrast of measured concentration of NO2 over a 
period of eight years. In another study Wang and colleagues (2013) showed that LUR model 
provided reliable estimates over a period of seven years in Metro Vancouver, in Canada, without 
loss of applicability of the model. Gulliver and colleagues (2013) evaluated back-extrapolation of 
LUR models for annual mean NO2 concentration developed in Great Britain for a period of up to 
18 years, demonstrating a valid reliability. In our cohort sample, we back-extrapolated air pollution 
data for eighteen years of follow-up. We used the ratio method proposed by ESCAPE project and 
we applied it to NO2, PM2.5 and PM2.5Absorbance to back-extrapolate LUR models.  
 
Firstly, we back-extrapolate data for 1995 for NO2, PM2.5 and PM2.5Absorbance and we calculated the 
annual average exposure to these pollutants for the whole period of follow-up. We found that the 
annual mean concentrations in 1995 for NO2, PM2.5 and PM2.5Abs for the participants were 6.28 
µg/m3 for Pm2.5, 0.81 ·10
-5 m-1 for Pm2.5Abs and 4.38 µg/m
3 for NO2, with a slight decrease over 
the years for all the three pollutants. Secondly, because the historical measurement for NO2 started 
earlier in time, we were able to calculate the early-life exposures for NO2 and PM2.5Absorbance, 
considered as the period in which children were aged between three and four years of age. During 
all the periods investigated the concentrations were below the limit suggested by the WHO 
guidelines corresponding to 10 μg/m3 for Pm2.5 and 40 μg/m
3 for NO2 (WHO, 2006), while no 





Our main interest in this study was to estimate the individual early-life exposure to the main air 
pollutants, such as NO2, PM2.5 and PM2.5Absorbance in the Raine Study participants. Intrauterine and 
early years of life are considered vulnerable periods because the lungs are still developing and 
ideally, we would back-extrapolated land use regression models since these periods. However, 
modelling historic air pollution exposure depends on the availability of monitored concentrations. 
Thus, one limitation of this study is that we were not able to back-extrapolate air pollution data to 
cover the antenatal period and in the first three years of life because monitoring measurements for 
PM2.5 and NO2 were consistently available starting from 1995 for PM2.5 and from 1993 for NO2. 
Our early life exposure was defined when children were aged between three and four years of age. 
Further, potential errors might be occurred with changing address in early life. Despite a wide 
range of studies reported adverse effect of air pollution on lung function, only few studies have 
investigated long-term exposure, and this can be mostly due to the limited data available from the 
monitoring stations. Another consideration is that air pollution measurements across monitoring 
stations were scarce in 1991 and 1992 comparing to the following years, so the accuracy of our 
data for those years were not completely reliable, resulting in high concentrations level in those 
earlier years (Supplementary Figure 4.1). Another limitation is that the land use regression model 
used for our analysis was developed and validated for the Metropolitan area of Perth in 2012. Thus, 
to estimate early-life air pollution exposure we back-extrapolated data for a period longer than 17 
years. Although various studies had demonstrated the stability of land use regression models over 
a period of 35 years, one of the assumptions when utilizing this approach is that the spatial pattern 
remains constant in time. However, it might be possible that from 1993 to 2012, Perth has 
undergone changes in the urban environment, such as the increasing of the road that can have 
overestimate the exposure at residential address. Further, we could not evaluate the accuracy of 
our air pollution estimates, as the LUR model that we used was the first and the only one developed 
for the area of Perth.  
On the other hand, this study has several strengths, such as the use of a longitudinal study with 
more than 22 years of follow-up with complete data on the residential address history for each 
participant. With the available air pollution data for each participant’s residential address, we were 
able to define different time frame of exposure (in early-life, in 1995, and lifetime average 
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exposure). Although most studies have assessed air pollution exposure using central site monitors, 
this study provides reliable exposure measurements as we had complete address histories from 
birth into young adulthood and we assigned exposures in early life according to the residential 
address through this period. The individual early life exposure to PM2.5, PM2.5Absorbance and NO2 
would serve as predictors in the analysis conducted on the next Chapter, to investigate the early-
life factors associated with the lung function trajectories previously identified.  
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4.5. Supplementary material 
 

























year Caversham Duncraig  N Rockingam PerthCBD QuinnsRock Rockingam SouthLake Swanbourne Wattleup 
1989                   
1990 
 From 
August       X           
1991 X      X           
1992 
X      X 
From 
October     
From 
September   
1993 X      X  X      X   




July     
Only 
December      X   
1996 X  X  X    X      X   
1997 X  X  X    X      X   
1998 X  X  X    X      X   
1999 X X  X    X      X   
2000 
X  X  X    X   
From 
March   X   
2001 X  X X    X    X  X   
2002 X  X  X    X    X  X   
2003 X  X  X    X    X  X   
2004 X  X  X    X    X  X   
2005 X X  X   X    X  X   
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2006 X  X  X    X    X  X   
2007 X  X  X    X    X  X   
2008 X  X  X    X    X  X   
2009 X  X  X    X    X  X   
2010 X  X X    X    X  X   
2011 X  X  X    X    X  X   
2012 X  X  X    X    X  X   
2013 X  X  X  X  X   












Supplementary Table 4.2. Available PM2.5 data obtained by Department of Environment (DER) 







PerthCBD QuinnsRock Rockingam SouthLake Swanbourne Wattleup 
1989                   
1990                   
1991                   
1992                   





November            From June   
1995  X  X               
1996  X  X             
1997  X  X             
1998  x  X             
1999  X  X             
2000 X  X             
2001  X  X             
2002  X  X             
2003  X  X             
2004 
 Only 
January  X             





May  X      From June    From March      
2007  X  X      X    X     
2008  X  X      X    X     
2009  X  X      X    X     
2010  X  X      X    X     
2011  X  X      X    X     
2012  X  X      X    X     
2013 X X   X  X   






Supplementary Table 4.3 A, B. Descriptive summary of PM2.5Absorbance and NO2 at home address for 
the first year of life and the lifetime average between the first year of life and 22 years of age in the 



























1991 1.96  ±0.70 0.12 5.29 
1991- 2012 0.98 ±0.36 0.15 3.58 
During the years of 
follow up (1993-2012) 




Std Dev Min Max 
1991 10.73 ±3.81 0.14 21.49 
1991- 2012 5.28 ±1.91 0.12 17.9 
During the years of 
follow up (1993-2012) 
4.35 ±1.46 0.09 12.03 
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Early-life risk factors on lung function trajectories in the 




A variety of factors associated with both the environment and lifestyle that are present from the 
fetal period into adulthood may present during important window of opportunities leading to 
development of respiratory diseases (Stocks, Hislop & Sonnappa, 2013). They can impact the 
natural lung function growth resulting in abnormal lung function trajectories that can track into 
adulthood.  
 
Several birth-cohort studies have shown that there is a distribution of different lung function 
trajectories in the population (Turner et al., 2014; Lødrup Carlsen et al., 2014; Belgrave et al., 
2014; Bui et al., 2018; Karmaus et al., 2019) and individuals have unique lifetime lung function 
trajectories based on their own life experiences. Together with respiratory infections, maternal 
tobacco use, preterm birth and allergens, air pollution is also a risk factor for respiratory health 
where children are considered more vulnerable than adults. Although the full implications of this 
finding are unknown, it is postulated that this increased vulnerability may be associated with 
relatively larger lung surface area in children (Kim et al., 2018). A birth-cohort study (Rice et al., 
2018) suggested that exposure to ambient pollution at relatively low levels may reduce lung 
function and increase risk of lung function deficits in mid-childhood. To date, there is an urgent 
need to further investigate lung function over the lifespan and identify groups at higher risk of lung 
disease and modifiable exposures.  
 
In our study, we hypothesized that insults in early life and exposure to ambient pollution are 
associated with low lung function trajectories. This study aimed to identify early-life, parental, and 
environmental predictors associated with the lung function trajectories identified. Only conditions 
determined before age six were considered as risk factors. In this Chapter, I investigated early life, 
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parental, and environmental predictors for the FEV1, FVC, FEV1/FVC lung function trajectories 




5.2.1. Study population 
We included participants from the Raine Study with two or more spirometry measurements from 
6 to 22 years. The cohort description was fully reported in Chapter 3.  
 
5.2.2. Statistical analysis 
The distribution of participants’ characteristics by lung function trajectories were summarized 
using percentages, and Person’s chi-squared tests were used to estimate differences between 
groups. Significance of the associations between lung function trajectories and potential risk 
factors were first evaluated by unadjusted multinomial logistic regression. Variables and all the 
childhood, parental and environmental predictors associated with lung function trajectories with 
p<0.1 were used to build the full model. The associations between early life and parental predictors 
with lung function trajectory membership were estimated through relative risk ratios (RRR) with 
95% confidence intervals (95% CI) obtained by multinomial logistic regression models. We used 
the lung function trajectories as the dependent variable and childhood, parental and environmental 
predictors associated with lung function trajectories as independent variables. The likelihood ratio 
test was used to compare the fit of the models. The final multinomial regression model was 
adjusted for gender, socioeconomic status, preterm birth, childhood asthma, childhood respiratory 
infections, childhood atopy, maternal smoking, parental asthma, parental hay fever, parental 
eczema, and early life exposure to NO2 and PM2.5Absorbance. Because wheeze was highly correlated 
with asthma, we removed this variable from the final model. However, we conducted a further 
analysis adjusting for childhood and parental wheeze instead of childhood and parental asthma 
(Supplementary Table 5.2). Further, as the sample size within individual lung function trajectory 
groups was low, we performed a sensitivity analysis dichotomizing or removing those variables 





To identify early-life and parental predictors associated with low lung function trajectories, we 


















Childhood wheeze was prevalent in the very low trajectory of FEV1 compared with the average 
trajectory (29.2% vs 18.6%, p=0.042). No statistically significant association was found between 
childhood asthma and asthma ever with different FVC trajectories. The prevalence of asthma was 
higher in the very low trajectory of FEV1/FVC. Specifically, as compared with those in the average 
trajectory, participants in the very low trajectory were more likely to have early onset asthma (13.0 
% vs 7.3%, p=0.010), persistent asthma (4.6% vs 0.9%, p=0.010), and late-onset asthma (8.4% vs, 
6.3% p=0.010). We found a significantly higher percentage of participants with childhood wheeze 






n= 2900 pregnancy women recruited 
from the public clinic at King 
Edward Memorial Hospital in Perth, 
Western Australia  
n=2868 live births 
n=1512 lung function trajectories 
of FEV1, FVC and FEV1/FVC 
 
with at least one FEV1 and FVC 
spirometry measurement at age 6,14, and 















with at least two spirometry 
measurement of FEV1 and FVC at age 







(32.6%) and parental wheeze (59.2%) in the very low trajectory of FEV1/FVC compared with the 
average trajectory. Among the trajectories, preterm birth was prevalent in the low trajectories of 
FEV1/FVC compared to the average trajectory (9.6% vs 5.0%). Prevalence of childhood and 
parental characteristics within lung function trajectories are reported in Table 5.1.
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Table 5.1.  Childhood and parental characteristics in participants with two or more spirometry measurements within FEV1, FVC and 
FEV1/FVC lung function trajectory groups 
 FEV1  FVC FEV1/FVC  














































































































































































































































































Atopic status at age 6 





























































































































































































































































































































































































































































































































Parental Hay Fever  
No 26 
(51.0) 




























































































































Note. *All values are given as frequencies with percentages in parentheses. **Significance of differences was evaluated by chi-square test and are given in bold. 
***SES= socio economic status, LRTI= low respiratory tract infections in the first year of life, URTI= upper respiratory tract infections in the first year of life 
****The average trajectory of FEV1, FEV1/FVC and FVC were used as reference category.
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Associations between childhood, parental, environmental predictors, and lung function trajectories 
are shown in Table 5.2. The final model was selected based on the predictors with a p-value <0.1 
in the unadjusted analysis (Supplementary Table 5.1) 
Participants in the very-low trajectory of FEV1 and FVC were more likely to have late-onset 
asthma (RR=6.52, 95% CI: 1.17- 36.23, p=0.032 and RR=6.75, 95% CI: 1.57- 28.93, p=0.010, 
respectively) when compared with the reference group. Participants in the above average trajectory 
of FVC were less likely to be exposed to maternal smoke compared with those in the average 
trajectory (RR=0.42, 95% CI: 0.18- 0.96, p=0.040). Having food allergies during childhood was 
associated with the very low trajectory of FEV1/FVC (RR= 3.11, 95% CI: 1.16- 8.34, p= 0.025). 
Participants in the very low trajectory of FEV1/FVC were more likely to be exposed to maternal 
smoke in pregnancy (RR=3.80, 95% CI: 1.01- 14.27, p= 0.048) or to be exposed to both pre- and 
post-natal maternal smoking (RR=3.52, 95% CI: 1.64- 7.57, p=0.001).  The high-low trajectory 
was associated with maternal smoke when children was aged five (RR=2.16, 95% CI: 1.06-4.40, 
p=0.035). Participants in the very low trajectory of FEV1/FVC had 3.18 times the risk to have 
paternal eczema, compared with those in the average trajectory (95% CI: 1.09-9.28, p= 0.034). An 
association between early-life exposure to air pollutants and the trajectories of FEV1/FVC was 
found for PM2.5Abs and NO2 (RR=0.25, 95% CI: 0.07-0.82, p= 0.022 and RR=1.27, 95% CI:1.03-
1.57, p= 0.022, respectively). Although childhood and parental wheeze were associated with lung 
function trajectories in the unadjusted analysis, we did not include them in the full model as these 
variables were included in the definition of asthma (“Have you wheezed in the last 12 months?”). 
A further analysis was carried out adjusting for childhood and parental wheeze instead of 
childhood and parental asthma (Supplementary Table 5.2), in which food allergies, maternal 
smoke, father eczema and air pollution exposure were no longer significant on the FEV1/FVC lung 
function. In the sensitivity analysis (Supplementary Table 5.3.) we observed that late-onset and 
persistent asthma combined were not associated with low FEV1 or FVC lung function trajectories. 
Further, participants whose mothers smoked in pre- or post-natal life had a lower risk to be in the 




Table 5.2. Association between childhood, parental factors, air pollution exposure and FEV1, FVC and FEV1/FVC lung function trajectories in Raine 
participants with two or more spirometry measurements (adjusted for gender, socioeconomic status, preterm, childhood asthma, childhood respiratory 
infections, childhood atopy, maternal smoking, parental asthma, parental hay fever, parental eczema, early life exposure to NO2 and PM2.5Absorbance). 
 FEV1 (n=1512)  FVC (n=1512)  FEV1 /FVC (n=1512) 
Variable Very low Low Above average Very low Low Above average Very Low Low-High High-Low 
Females  0.42 (0.12- 1.51) 0.89 (0.63- 1.26) 1.30 (0.71- 2.41) 0.81 (0.31- 2.15) 0.63 (0.44- 0.92) 0.68 (0.39- 1.21) 1.05 (0.56- 1.98) 0.76 (0.46- 1.26) 0.75 (0.51-1.11) 
SES          
16000-40000 3 participants 1.06 (0.53-  
2.14) 
0.87 (0.26- 2.94) 32 participants 0.76 (0.35- 1.67) 0.55 (0.18- 1.72) 1.84 (0.37- 9.19) 0.58 (0.21- 1.60) 0.73 (0.34- 1.56) 
≥40000 15 participants 0.97 (0.48- 1.95) 0.68 (0.21- 2.27) 24 participants 0.69 (0.32- 1.51) 0.54 (0.18- 1.65) 2.44 (0.49- 12.23) 1.05 (0.39- 2.83) 0.64 (0.30- 1.36) 
Preterm 3 participants 1.43 (0.73- 2.80) 0.34 (0.04- 2.73) 0.73 (0.08- 6.88) 1.35 (0.63- 2.88) 0.67 (0.17- 2.61) 0.69 (0.13- 3.59) 2.06 (0.80- 5.30) 2.36 (1.09- 5.09) 
Respiratory 
Infections 
         
URTI only 0.32 (0.05- 2.09) 0.92 (0.63- 1.34) 1.45 (0.75-2.80) 0.47 (0.15- 1.49) 0.84 (0.56- 1.26) 0.96 (0.52- 1.78) 0.89 (0.45- 1.78) 0.96 (0.55- 1.66) 0.94 (0.62-1.43) 
LRTI or both 2.72 (0.66-11.19) 1.45 (0.90- 2.32) 1.45 (0.60- 3.54) 0.96 (0.28- 3.32) 1.36 (0.80- 2.29) 1.40 (0.63- 3.09) 0.85 (0.34- 2.13) 1.68 (0.89- 3.17) 1.25 (0.75-2.10) 
Asthma          
Early-onset 2.47 (0.24- 25.60) 1.15 (0.63- 2.10) 1.09 (0.34- 3.49) 1.40 (0.26- 7.42) 1.06 (0.54- 2.07) 1.53 (0.58- 3.99) 2.43 (0.89- 6.67) 1.48 (0.64- 3.40) 1.02 (0.51- 2.07) 
Persistent 2 participants 1.49 (0.37- 6.07) 1.73 (0.17- 18.04) No participants 1.69 (0.32- 9.06) 3.19 (0.39- 26.18) 6.17 (0.87- 43.72) 1.41 (0.13- 15.10) 2.19 (0.44-  10.85) 
Late-onset 6.52 (1.17- 36.23) 0.90 (0.45-1.83) 0.31 (0.04- 2.44) 6.75 (1.57- 28.93) 1.67 (0.68- 4.09) 2.93 (0.90- 9.53) 2.24 (0.56-  8.93) 
2.59 (1.00- 6.72) 2.19 (0.97- 4.92) 
Atopy (IgE) 
at age 6 
 
 
       
Food Allergy 
(only) 
2.94 (0.62-13.87) 0.96 (0.48-1.91) 1.20 (0.37- 3.92) 1.42 (0.31-  6.42) 0.77 (0.38- 1.57) 0.80 (0.24- 2.65) 3.11 (1.16- 8.34) 0.31 (0.07- 1.38) 1.06 (0.51- 2.21) 
Aeroallergens 
(only) 
1 participant 1.82 (0.93-  
3.57) 
1.41 (0.37- 5.41) 0.56 (0.06- 5.13) 1.31 (0.62- 2.78) 1.33 (0.42- 4.22) 0.44 (0.09-  2.09) 0.63 (0.24- 1.66) 0.67 (0.32- 1.40) 









4.28 (0.55- 33.31) 0.40 (0.14- 1.10) 1.23 (0.37-  4.12) 2.71 (0.45-16.39) 0.50 (0.18- 1.36) 1.66 (0.53-5.25) 3.80 (1.01- 14.27) 1.11 (0.28- 4.40) 
 
1.49 (0.54-  4.02) 
Smoke at 6 
only 
No participants 1.01 (0.53- 1.91) 0.41 (0.09- 1.88) 5 participants 0.81 (0.41- 1.60) 0.40 (0.11-1.50) 2.93 (0.93- 9.29)  1.70 (0.62- 4.68) 2.16 (1.06- 4.40) 
Both  1.34 (0.27- 6.61) 1.05 (0.67- 1.63) 0.42 (0.15- 1.15) 0.95 (0.29- 3.05) 0.66 (0.41- 1.07) 0.42 (0.18- 0.96) 3.52 (1.64- 7.57) 1.79 (0.95- 3.39) 1.45 (0.87- 2.42) 
Parental 
Asthma 
         
Mother 
Asthma only 
2.21 (0.49- 10.05) 0.98 (0.59- 1.62) 0.59 (0.19- 1.85) 2.80 (0.88- 8.91) 1.13 (0.65- 1.96) 0.52 (0.19- 1.40) 0.67 (0.24- 1.86) 0.82 (0.38- 1.76) 1.31 (0.76- 2.25) 
Father 
Asthma only 
2.64 (0.36-19.3) 0.84 (0.45- 1.60) 0.58 (0.15- 2.21) 1.67 (0.29- 9.70) 1.01 (0.50- 2.03) 0.65 (0.21- 2.05) 1.04 (0.32- 3.35) 0.72 (0.26- 1.97) 1.49 (0.74-  2.98) 
Both No participants 1.41 (0.44- 4.58) 1.04 (0.11- 10.37) 3.26 (0.27- 38.91) 1.06 (0.30- 3.82) 0.41 (0.04- 4.25) No participants 0.50 (0.05- 4.61) 1.66 (0.51- 5.42) 
Parental 
Hayfever 
         
Mother 
Hayfever 
0.24 (0.04- 1.50) 0.84 (0.56-1.27) 1.06 (0.50-  2.24) 1.09 (0.33- 3.61) 0.76 (0.48- 1.19) 1.04 (0.52- 2.10) 0.58 (0.25- 1.33) 0.68 (0.36- 1.27) 1.12 (0.71- 1.76) 
Father 
Hayfever 
0.43 (0.06- 3.03) 0.81 (0.49- 1.33) 1.21 (0.51- 2.89) 1.18 (0.29- 4.85) 0.70 (0.41- 1.20) 
 
1.11 (0.50- 2.47) 1.48 (0.66- 3.33) 1.02 (0.51- 2.04) 1.10 (0.63- 1.94) 
Both 0.49 (0.08- 3.03) 0.80 (0.47-1.36) 0.98 (0.38- 2.52) 1.42 (0.35- 5.80) 1.00 (0.55- 1.80) 1.44 (0.61- 3.42) 0.68 (0.23-2.05) 1.54 (0.75- 3.16) 1.38 (0.76- 2.48) 
Parental 
Eczema 





1.28 (0.27- 5.99) 1.03 (0.66- 1.62) 0.66 (0.27- 1.62) 1.46 (0.49-  4.35) 0.62 (0.38- 1.01) 0.83 (0.40- 1.72) 1.83 (0.84- 3.96) 0.59 (0.28- 1.22) 0.91 (0.55-  1.49) 
Father 
Eczema only 
9.73 (1.19- 79.53) 1.69 (0.85- 3.38) 0.63 (0.13- 2.97) 4.40 (0.92- 21.0) 1.09 (0.52- 2.31) 0.90 (0.27- 3.04) 3.18 (1.09- 9.28) 0.98 (0.33- 2.88) 1.77 (0.83-  3.76) 
Both 1 participant 0.79 (0.31- 2.04) 3 participants 1 participant 0.63 (0.23- 1.71) 0.32 (0.04- 2.80) 0.95 (0.11- 8.51) 0.96 (0.23- 4.08) 1.33 (0.46-  3.86) 
PM2.5Absorbance 
(early life) 
1.28 (0.13- 12.45) 0.70 (0.39-1.25) 0.85 (0.31- 2.38) 2.57 (0.52- 12.70) 1.05 (0.56- 1.96) 1.18 (0.46- 3.06) 0.25 (0.07- 0.82) 0.47 (0.20- 1.11) 0.68 (0.36- 1.28) 
NO2 
 (early life) 
0.87 (0.58- 1.30) 0.98 (0.88- 1.09) 1.01 (0.83- 1.23) 0.80 (0.59-1.09) 0.98 (0.87- 1.11) 0.96 (0.80-  1.16) 1.27 (1.03- 1.57) 1.04 (0.89-  1.21) 1.00 (0.89- 1.13) 
 
Note. *Relative Risk Ratios (95% confidence intervals) and significance differences from the average trajectory were derived from a multinomial logistic 
regression. **Bold values indicate a significant association at α= 0.05. ***SES=socio economic status, LRTI= low respiratory tract infections in the first year of 




Important early-life predictors of low lung function trajectories were asthma, atopy, maternal 
smoke, paternal eczema, and early life exposure to air pollutants. In addition, childhood wheeze 
was associated with the very low trajectory of FEV1 and females were more likely to belong to the 
low trajectory of FVC compared with males. Regarding other potential risk factors, parental 
asthma and parental hay fever were not significantly associated with lung function trajectories in 
this study cohort.   
 
The present study showed that asthma was an important predictor for belonging to low trajectories 
of FEV1 and FVC. In fact, having late-onset asthma was associated with a more than 6- fold 
increased risk of having a very low lung function trajectory compared to an average trajectory, 
suggesting that participants in the low trajectory have an increased risk of asthma in later life, or 
it might be that risk factors associated to low lung function trajectories across childhood are also 
associated with late-onset asthma. We also found that the prevalence of early-onset, persistent and 
late-onset asthma was higher in the very low trajectory of FEV1/FVC compared with the average 
trajectory. Childhood asthma was a significant predictor of low lung function trajectories of FEV1 
and FEV1/FVC in the unadjusted multivariate analysis but was no longer significant in the full 
adjusted model.  
 
A limited number of previous studies have investigated childhood asthma in relation to lung 
function trajectories. In the Tucson Children’s Respiratory Study cohort, Berry et al (2016) found 
that the prevalence of children with asthma was more than 3-times higher in the low trajectory of 
FEV1/FVC compared with the normal trajectory (26.4 vs 7.7%, p<0.001). Childhood asthma was 
found to be associated with the low lung function trajectories identified in the Tasmanian 
Longitudinal Health Study (TAHS) cohort (Bui, 2019), while other studies reported the same 
association in males, but not in females (Karmaus et al., 2019). Although we defined late-onset, it 
should not be confused with adulthood asthma, as in our study late-onset might occur after five 
years of age. To the best of our knowledge this is the first study to investigate asthma phenotypes 




Participants in the above average trajectory of FVC were less likely to be exposed to maternal 
smoke compared with those in the average trajectory. An association was also seen between the 
very low trajectory of FEV1/FVC and maternal smoking both in pregnancy or when the child was 
aged five years – but not if they only have smoked when the child was five years of age. The effect 
of maternal smoking during pregnancy and post-natal life has been widely investigated but its role 
on lung function trajectories is not well elucidated as very few studies have been conducted. Our 
findings are in line with previous research in which maternal smoking was associated with lower 
FEV1 in adulthood (Bui et al., 2019; Svanes et al., 2010). However, in the Isle of Wight birth cohort 
in the UK (Karmaus et al., 2019) being exposed to smoke during pregnancy was not considered as 
a risk factor of being in the low lung function trajectories.  There are several potential explanatory 
mechanisms for the influence of maternal smoking on lung function over life, mostly derived by 
animal studies (Xiao et al., 2011; Spindel et al., 2016). In utero exposed mice showed that nicotine 
receptors mediate most of the effect of maternal smoking on lung development (Xiao et al., 2011). 
This was confirmed by analysis on airway size and diameter, showing an increased number of 
airways of small diameter with nicotine treatment. Another mechanism that appears to mediate the 
effect of nicotine exposure on lung development and the effect of maternal smoking during 
pregnancy was the oxidative mechanisms. Multiple studies demonstrated that prenatal nicotine 
exposure increases markers of oxidative damage. In fact, the lungs are smaller in offspring, with 
larger alveoli, and a reduction in alveolarization (Maritz & Harding, 2011).  Our results suggest 
that maternal smoking affects the lung capacity of their children, making the volume that is 
associated with the FVC smaller compared with children whose mother did not smoke during 
pregnancy or in the first years of children’s life. Even if we have not found an association with 
FEV1, parental smoke seems to be associated with an increased risk of airway obstruction, as 
defined by a low FEV1/FVC trajectory. 
 
Our findings suggest that early life exposure to NO2 was associated with the very low lung function 
trajectories of FEV1/FVC, A study conducted in Australia (Salimi et al., 2018) showed that low 
levels of NO2 were associated with more hospitalizations for asthma, suggesting that even 
concentration levels lower than those recommended by the WHO might have an effect on 
respiratory health. Unexpected, our results showed that early life exposure to PM2.5Absorbance was 
negatively associated with the very low trajectory of FEV1/FVC (RR=0.25, 95% CI: 0.07- 0.82). 
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Despite plausible biological mechanisms, the role of ambient air pollution in the development of 
respiratory diseases through life is still uncertain. To the best of our knowledge, this is the first 
study on lung function trajectories of FEV1, FVC and FEV1/FVC that also considered the impact 
of early-life exposure to air pollutants. Our results need to be interpreted carefully. Firstly, because 
we back-extrapolated air pollution data for nineteen years of follow-up and we might overestimate 
the results, as significant alterations in the urban landscape will have occurred over this period.  
Some, but not all, areas in Perth may have undergone significant re-development or expansion that 
might have led to prediction error from our models. Although other studies (Beelen et al., 2007; 
Gulliver, 2013) have suggested that LUR are stable even over a period of 35 years, the performance 
of the model would be weaker and we were not able to verify the accuracy of our estimation, due 
to the fact that the LUR we used in our analysis was the only one developed for the Perth area. 
Secondly, the availability of monitoring station during the early 90’s was limited. Further, we were 
not able to measure air pollution in the gestational and the first years of life in which lung 
morphology changes dramatically. More studies should be conducted both in low and high-level 
concentrations settings in order to further our understanding of the long-term effects of air 
pollution exposure at specific periods, especially before and after birth.   
 
 
In our study, the history of paternal eczema was associated with the very low trajectory of 
FEV1/FVC.  The Copenhagen Prospective Study on Asthma in Childhood, neonatal lung function 
was not affected by parental- mother or father- atopic diseases, such as eczema or allergic rhinitis 
(Bisgaard et al., 2009). However, there is no previous evidence reporting the relationship between 
paternal eczema and lung function trajectories. We observed an association between childhood 
food allergies and the very-low trajectory of FEV1/FVC. These findings are in line with a study 
conducted within the Chicago Food Allergy cohort, in which having food allergies was a risk factor 
for greater small airway airflow obstruction among children. Other studies (Friedlander er al., 
2013) reported that individuals with asthma with multiple food allergies had significantly 
decreased FEV1 and FEV1/FVC compared to individuals with asthma but without any food 
allergies. However, this study included only participants with asthma. Food allergy is a reaction 
of the immune system triggered by the ingestion of a food protein antigen. The exposure to 
allergenic food can lead to clinical symptoms, including airway inflammation. It is yet unclear if 
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having food allergies in childhood is an independent risk factor for decreasing lung function 
despite the asthma status. 
 
Males were more likely to belong to the low lung function trajectory of FVC, while preterm 
children were more likely to belong to the high-low trajectory of FEV1/FVC. Socioeconomic 
status, respiratory infections, and parental hay fever were not found to be associated with the lung 
function trajectories of FEV1, FVC or FEV1/FVC. Previous research showed a lack of association 
between children’s respiratory health and socioeconomic status (Gehring et al., 2006), while others 
supported the hypothesis of the association between social economic status and respiratory 
outcomes in children, such as the diagnosis of asthma (Gong et al., 2014) with different effects 
depending on race and ethnicity (Thakur et al., 2013).  
 
When we conducted the sensitivity analysis, late-onset and persistent asthma combined was no 
longer associated with low lung function trajectories, along with maternal smoking. Discrepancies 
with our main results may be partly due because the model was not adjusted for all the confounders, 
such as preterm and socio-economic status as they consist of few participants within trajectories. 
Another explanation is that the combination in categories might have reduced accuracy and we 
might have lost part of the information, such as the association of low lung function trajectories as 
a function of asthma phenotypes. Therefore, we have chosen to present the results from the first 
approach. 
 
The main limitation of this study is that although we investigated the early-life exposure to 
PM2.5Absorbance and NO2 for each participant, we were not able to include exposure during other 
important susceptible periods before five years of age, such as pregnancy and the very first years 
of life as the earliest available measure was when children were aged between 3.5 and 4.5 years. 
A strength of the study was that the longitudinal design from a large cohort allowed us to 
investigate the early life factors associated with lung function trajectories defined for an Australian 
cohort. Demographics and clinical information of children and their parents were available from 
pregnancy and for the years of follow up, including repeated spirometry measurements from 




To conclude, taken together, these results provide further insight into the emerging knowledge of 
lung function trajectories for different respiratory markers. We identified childhood atopy, asthma, 
maternal smoke, paternal eczema, and early life exposure to air pollution as risk factors for low 




5.5. Supplementary material 
 
Supplementary Table 5.1. Association between childhood, parental factors, air pollution exposure and FEV1, FVC and FEV1/FVC lung function 
trajectories in Raine participants with two or more spirometry measurements (unadjusted) 
 FEV1 (n=1512)  FVC (n=1512)  FEV1 /FVC (n=1512) 
Variable Very low Low Above average Very low Low Above average Very Low Low-High High-Low 
Females  0.61 (0.34- 1.10) 1.03 (0.84- 1.28) 0.88 (0.58- 1.33) 0.67 (0.39- 1.15) 1.05 (0.84-1.32) 0.88 (0.60- 1.29) 0.83 (0.57- 1.22) 1.17 (0.85- 1.61) 0.80 (0.63-1.00) 
SES          
16000-40000 2.24 (0.66- 7.61) 0.98 (0.65- 1.43) 1.33 (0.59-2.98) 2.13 (0.62- 7.35) 0.84 (0.54-1.29) 0.67 (0.35- 1.28) 1.05 (0.52-2.13) 0.60 (0.33-1.07) 0.77 (0.51-1.18) 
≥40000 1.09 (0.30- 3.88) 1.06 (0.72-1.55) 1.11 (0.50-2.51) 1.43 (0.41- 5.01) 0.82 (0.53- 1.25) 0.62 (0.32- 1.19) 0.91 (0.45- 1.85) 0.95 (0.54- 1.67) 0.74 (0.48 1.12) 
Preterm 1.04 (0.31- 3.51) 1.30 (0.84- 2.00) 0.97 (0.40- 2.37) 1.51 (0.60- 3.79) 1.03 (0.65- 1.62) 0.85 (0.38-1.90) 0.94 (0.38- 2.30) 2.03 (1.11- 3.71) 1.92 (1.20- 3.08) 
Respiratory 
Infections 
         
URTI only 0.41 (0.19- 0.90)  0.80 (0.63- 1.03) 1.13 (0.71- 1.81) 0.59 (0.31- 1.15) 1.01 (0.78- 1.31) 1.26 (0.82- 1.93) 0.81 (0.52- 1.25) 1.06 (0.74- 1.52) 0.91 (0.70- 
1.19) 
LRTI or both 1.27 (0.66- 2.46) 1.01 (0.76- 1.34) 1.08 (0.62- 1.89) 0.98 (0.50- 1.88) 1.05 (0.78- 1.41) 0.97 (0.58- 1.62) 1.01 (0.62- 1.63) 1.12 (0.74- 1.69) 1.03 (0.77- 1.39) 
Asthma          
Early-onset 1.00 (0.30- 3.41) 1.45 (0.99-2.13) 0.85 (0.37-1.94) 0.97 (0.37- 2.59) 0.94 (0.63- 1.39) 0.78 (0.38-1.60) 2.34 (1.28-4.26) 1.28 (0.71-2.29) 1.41 (0.93- 2.14) 
Persistent 3.85 (0.79-18.9) 1.32 (0.54- 3.26) 0.70 (0.87- 5.67) No participants 1.01 (0.40- 2.55) 1.43 (0.36- 5.62) 6.58 (2.08-20.94) 1.80 (0.45- 7.30) 1.80 (0.62- 5.24) 
Late-onset 2.34 (0.98- 5.61) 0.94 (0.62- 1.43) 0.61 (0.24-1.56) 1.61 (0.59- 4.41) 1.34 (0.83- 2.15) 1.54 (0.75- 3.15) 1.77 (0.87-3.59) 
1.41 (0.77- 2.58) 1.29 (0.81- 2.03) 
Wheeze at age 6 1.81 (0.94-3.48) 1.40 (1.07-1.84) 1.01 (0.58- 1.76) 1.46 (0.79- 2.72) 1.15 (0.86- 1.53) 1.17 (0.73- 1.88) 2.18 (1.43-3.32) 1.25 (0.84- 1.86) 1.39 (1.04-1.87) 
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Food Allergy 
(only) 
1.52 (0.56- 4.14) 1.05 (0.67- 1.64) 0.71 (0.24- 2.08) 0.84 (0.28-2.52) 0.79 (0.50- 1.24) 0.53 (0.20- 1.42) 1.83 (0.96- 3.49) 0.51 (0.22- 1.18) 0.97 (0.60- 1.57) 
Aeroallergens 
(only) 
0.32 (0.04- 2.42) 1.44 (0.94- 2.22) 0.94 (0.35- 2.51) 0.46 (0.10- 2.01) 1.07 (0.68- 1.69) 0.82 (0.37- 1.95) 0.58 (0.24- 1.40) 0.87 (0.47-1.60) 0.76 (0.48- 1.21) 
Both  0.91 (0.48- 1.72) 0.88 (0.69- 1.12) 1.56 (1.01- 2.43) 1.02 (0.57- 1.83) 0.85 (0.66- 1.10) 1.50 (0.99- 2.24) 0.95 (0.62- 1.46) 1.46 (0.59- 1.21) 0.98 (0.76- 1.27) 
Maternal 
Smoke 
         
Smoke in 
pregnancy only 
 0.98 (0.22- 
4.32) 
0.65 (0.37- 1.12) 1.62 (0.74- 3.55) 1.20 (0.34- 4.24) 0.70 (0.40- 1.23) 1.53 (0.72-3.29) 2.02 (0.83- 4.92) 1.23 (0.53-2.83) 1.83 (1.03- 3.24) 
Smoke at 5 only No participants  0.99 (0.66-1.50) 0.36 (0.10- 1.18) 1.76 (0.63- 4.93) 1.48 (0.91- 2.38) 0.49 (0.17- 1.45) 0.98 (0.44- 2.15) 0.78 (0.40-1.51) 0.91 (0.57- 1.43) 
Both  1.79 (0.89-3.62) 1.08 (0.81- 1.43) 0.61 (0.31- 1.16) 1.26 (0.64- 2.46) 0.74 (0.55- 0.99) 0.75 (0.45- 1.25) 2.57 (1.64- 4.02) 1.20 (0.77- 1.84) 1.44 (1.06- 1.97) 
Parental 
Asthma 
         
Mother Asthma 
only 
1.67 (0.77- 3.60) 0.97 (0.71- 1.33) 0.67 (0.34- 1.31) 1.82 (0.90- 3.69) 0.89 (0.64- 1.25) 0.88 (0.51- 1.53) 1.52 (0.88-2.60) 0.96 (0.59- 1.57) 1.59 (1.13- 2.22) 
Father Asthma 
only 
1.23 (0.41-3.68) 1.14 (0.77- 1.68) 0.56 (0.21-1.45) 1.52 (0.59- 3.91) 1.01 (0.66- 1.54) 0.72 (0.33- 1.55) 1.74 (0.91-3.33) 0.86 (0.45- 1.64) 1.56 (1.02- 2.38) 
Both No participants  1.55 (0.75- 3.16) 0.91 (0.20- 4.15) 1.56 (0.33- 7.34) 0.87 (0.42- 1.80) 0.49 (0.11- 2.24) 1.35 (0.38- 4.85) 0.96 (0.31-2.99) 1.80 (0.85-3.80) 
Parental 
Hayfever 
         
Mother Hayfever 0.67 (0.34- 1.31) 0.82 (0.63-1.06) 0.85 (0.50- 1.42) 0.96 (0.50- 1.82) 0.76 (0.58- 1.01) 1.10 (0.69- 1.78) 0.78 (0.49- 1.26) 1.10 (0.75-1.61) 0.95 (0.72- 1.25) 
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Father Hayfever 0.51 (0.20- 1.27) 0.75 (0.55-1.03) 0.97 (0.53- 1.76) 0.89 (0.42- 1.90) 0.59 (0.42- 0.82) 1.06 (0.61- 1.83) 1.39 (0.83- 2.35) 1.36 (0.85- 2.18) 1.22 (0.86-1.71) 
Both 0.47 (0.18-1.27) 0.73 (0.52-1.01) 1.02 (0.55- 1.89) 0.74 (0.30- 1.80) 0.74 (0.52- 1.05) 1.43 (0.82- 2.50) 0.91 (0.50-1.65) 1.16 (0.71- 1.89) 1.02 (0.72- 1.46) 
Parental 
Eczema 
         
Mother Eczema 
only 
0.37 (0.11- 1.23) 0.98 (0.73-1.34) 0.63 (0.32- 1.24) 0.84 (0.39- 1.82) 0.71 (0.52- 0.98) 0.74 (0.43- 1.27) 1.34 (0.80- 2.26) 0.71 (0.44-1.16) 0.94 (0.67- 1.31) 
Father Eczema 
only 
1.44 (0.47- 4.31) 1.37 (0.87-2.15) 1.00 (0.40-2.47) 1.64 (0.63- 4.23) 1.03 (0.64- 1.67) 0.75 (0.32- 1.79) 2.32 (1.19- 4.52) 0.92 (0.46- 1.86) 1.30 (0.80- 2.11) 
Both 0.56 (0.07- 4.33) 0.59 (0.30- 1.17) 0.78 (0.23- 2.70) 0.43 (0.06- 3.35) 0.55 (0.27- 1.07) 0.51 (0.15- 1.79) 0.66 (0.15- 2.92) 1.18 (0.48- 2.87) 0.94 (0.45- 1.94) 
Parental 
Wheezing 
1.76 (0.96- 3.21) 1.01 (0.81-1.26) 0.95 (0.62- 1.47) 1.16 (0.67- 2.01) 0.93 (0.73- 1.18) 1.09 (0.74-1.60) 2.17 (1.47- 3.21) 1.01 (0.72- 1.41) 1.29 (1.01- 1.63) 
PM2.5Absorbance 
(early life) 
0.29 (0.08-0.91) 0.80 (0.57-1.14) 1.18 (0.64-2.20) 0.79 (0.31-2.00) 0.99 (0.68- 1.45) 1.06 (0.59- 1.92) 0.63 (0.34- 1.17) 0.59 (0.35- 1.01) 0.57 (0.39- 0.85) 
NO2 
 (early life) 
0.81 (0.69-0.96) 0.96 (0.91-1.02) 1.07 (0.97-1.19) 0.92 (0.80- 1.06) 1.03 (0.97-1.09) 1.05 (0.95-1.16) 0.96 (0.87- 1.06) 0.92 (0.84-0.99) 0.93 (0.87-0.98) 
Note. *Relative Risk Ratio (95% confidence intervals) and significance differences from the average trajectory were derived from a multinomial logistic 
regression. **Bold values indicate a significant association at α= 0.1, while bold and Italic at <0.05 ***The model was unadjusted for covariates. 
****SES=socio economic status, LRTI= low respiratory tract infections, URTI= upper respiratory tract infections *****The average trajectory of FEV1, 






Supplementary Table 5.2. Association between childhood, parental factors, air pollution exposure and FEV1, FVC and FEV1/FVC lung function 
trajectories in Raine participants with two or more spirometry measurements (adjusted for gender, socioeconomic status, preterm, childhood respiratory 
infections, childhood wheeze, childhood atopy, maternal smoking, parental hay fever, parental eczema, parental wheezing, early life exposure to NO2 and 
PM2.5Absorbance). 
 FEV1 (n=1512) FVC (n=1512) FEV1 /FVC (n=1512) 
Variable Very low Low Above average Very low Low Above average Very Low Low-High High-Low 
Females  0.28 (0.09-0.86) 0.88 (0.64- 1.23) 1.29 (0.71- 2.35) 0.60 (0.26- 2.40) 0.68 (0.48- 0.97) 0.78 (0.45- 1.35) 0.89 (0.50- 1.58) 0.82 (0.51- 1.31) 0.76 (0.53-
1.09) 
SES          
16000-40000 29 participants 1.07 (0.57-  2.00) 1.57 (0.43- 5.78) 2.65 (0.31-22.83) 0.38 (0.38- 1.54) 0.85 (0.27- 2.67) 2.70 (0.60- 12.85) 0.56 (0.22- 1.38) 0.74 (0.37- 
1.47) 
≥40000 15 participants 1.05 (0.56- 1.97) 1.18 (0.32- 4.34) 1.54 (0.17-13.78) 0.80 (0.39- 1.61) 0.89 (0.29- 2.77) 3.18 (0.67- 15.16) 1.00 (0.41- 2.40) 0.67 (0.34- 
1.33) 




         
URTI only 0.89 (0.25- 3.12) 0.90 (0.63- 1.29) 1.23 (0.65- 2.35) 0.72(0.27- 1.88) 0.81 (0.55- 1.19) 0.79 (0.43- 1.45) 0.86 (0.45- 1.62) 0.91 (0.54- 1.54) 0.99 (0.66-
1.48) 









at age 6 
 
 
       
Food Allergy 
(only) 




5 participants 1.88 (0.97-  3.65) 1.39 (0.37- 5.25) 0.46 (0.05- 3.94) 1.39 (0.66- 2.92) 1.45 (0.46- 4.57) 0.59 (0.16-  2.18) 0.60 (0.23- 1.60) 0.60 (0.29- 
1.24) 
Both   
15 participants 












Smoke at 5 
only 
No participants 1.20 (0.66- 2.20) 0.70 (1.2- 2.49) 5 participants 0.87 (0.46- 1.64) 0.40 (0.11-1.43) 2.29 (0.81- 6.51)  2.40 (1.02- 5.63) 1.85 (0.94- 
3.67) 








         
Mother 
Hayfever 






0.48 (0.11- 2.12) 0.80 (0.49- 1.29) 1.07 (0.46- 2.50) 1.19 (0.35- 4.03) 0.68 (0.41- 1.14) 
 
1.13 (0.52- 2.47) 1.39 (0.65- 2.95) 1.14 (0.58- 2.23) 1.27 (0.74- 
2.19) 




         
Mother 
Eczema only 




5.12 (0.87- 30.08) 1.66 (0.82- 2.97) 0.84 (0.23- 3.05) 2.81 (0.67- 11.80) 1.04 (0.52- 2.10) 0.95 (0.31- 2.87) 2.73  (1.03- 7.25) 0.98 (0.36- 2.66) 1.95 (0.97-  
3.93) 
Both Only one 
participant 




1.59 (0.24- 10.44) 0.74 (0.42-1.29) 0.85 (0.31- 2.34) 1.69  (0.42- 6.84) 1.03 (0.56- 1.91) 1.05 (0.41- 2.70) 0.43 (0.15- 1.23) 0.52 (0.23- 1.18) 0.64 (0.34- 
1.19) 
NO2 
 (early life) 





Note. *Relative Risk Ratio (95% confidence intervals) and significance differences from the average trajectory were derived from a multinomial logistic 
regression. **Bold values indicate a significant association at α= 0.1, while bold and Italic at <0.05 ***SES=socio economic status, LRTI= low respiratory 




Supplementary Table 5.3. Association between childhood, parental factors, air pollution exposure and FEV1, FVC and FEV1/FVC lung function trajectories 
in Raine participants with two or more spirometry measurements (adjusted for gender, childhood respiratory infections, childhood asthma, maternal 
smoking, parental asthma, parental hay fever, parental eczema, early life exposure to NO2 and PM2.5Absorbance). 
 FEV1 (n=1512)  FVC (n=1512)  FEV1 /FVC (n=1512) 
Variable Very low Low Above 
average 
Very low Low Above 
average 
Very Low Low-High High-Low 
Females  0.63 (0.20- 1.96) 0.93 (0.67- 1.29) 1.25 (0.69- 2.28) 1.60 (0.93- 2.72) 1.22 (0.66- 2.26) 1.13 (0.68- 1.90) 1.39 (0.74- 2.62) 1.21 (0.73- 1.99) 1.28 (0.89-1.86) 
Respiratory 
Infections 
         
URTI only 0.33 (0.06- 1.70) 0.86 (0.59- 1.24) 1.24 (0.50-3.05) 1.41 (0.76- 2.63) 1.56 (0.77- 3.13) 1.49 (0.42- 2.71) 1.07 (0.43- 1.76) 1.07 (0.61- 1.89) 1.06 (0.70-1.60) 
LRTI or both 2.31 (0.64-18.28) 1.39 (0.88- 2.20) 1.39 (0.73- 2.66) 0.91 (0.45- 1.83) 0.86 (0.80- 2.29) 1.07 (0.55- 2.09) 0.73 (0.30- 1.76) 1.27 (0.66- 2.44) 0.91 (0.55-1.50) 
Asthma          
Early-onset 0. 82 (0.09- 7.21) 1.01 (0.56- 1.84) 0.73 (0.21- 2.61) 0.73 (0.36- 1.49) 1.00 (0.32- 3.12) 1.04 (0.41- 2.63) 1.79 (0.67- 4.91) 1.20 (0.50- 2.91) 0.83 (0.42- 1.65) 
Persistent OR 
late-onset 
3.41 (0.80- 15.36) 0.99 (0.52- 1.88) 0.53 (0.11- 2.4) 0.82 (0.32- 2.12) 0.91 (0.31- 2.61) 0.56 (0.24- 1.45) 1.04 (0.35- 3.10) 1.13 (0.48- 2.62) 0.45 (0.21- 0.92) 
Maternal 
Smoke 
         
Smoke in 
pregnancy OR 
at a 6 
1.31 (0.25- 6.91) 0.69 (0.40- 1.17) 0.74 (0.29- 1.90) 1.07 (0.45-2.49) 1.16 (0.44- 3.01) 0.71 (0.31-1.64) 1.55 (0.64- 3.74) 0.75 (0.34- 1.67) 
 
0.50 (0.28- 0.90) 
Both  1.05 (0.25- 4.31) 1.04 (0.68- 1.61) 0.46 (0.17- 1.24) 0.81 (0.43- 1.54) 0.69 (0.32- 1.51) 0.58 (0.31- 1.10) 1.77 (0.84- 3.71) 1.06 (0.57- 1.99) 0.62 (0.37- 0.99) 
Parental 
Asthma 





2.69 (0.68- 10.60) 0.96 (0.58- 1.60) 0.57 (0.19- 1.78) 0.73 (0.36- 1.49) 0.26 (0.10- 0.71) 0.53 (0.26- 1.06) 0.66 (0.24- 1.81) 0.90 (0.43- 1.88) 0.77 (0.44- 1.35) 
Father Asthma 
only 
1.86 (0.31-11.15) 0.80 (0.43- 1.50) 0.58 (0.16- 2.07) 0.82 (0.31- 2.12) 0.41 (0.12- 1.37) 0.84 (0.34- 2.09) 0.49 (0.15- 1.60) 0.41 (0.14- 1.16) 0.59 (0.30- 1.13) 
Parental 
Hayfever 
         
Mother 
Hayfever 
0.27 (0.05- 1.35) 0.89 (0.59- 1.34) 1.08 (0.51- 2.26) 1.26 (0.64- 2.46) 1.25 (0.57- 2.73) 1.23 (0.65- 2.33) 0.53 (0.22- 1.22) 0.78 (0.42- 1.46) 0.97 (0.62- 1.53) 
Father 
Hayfever 
0.39 (0.07- 2.08) 0.76 (0.47- 1.22) 1.16 (0.50- 2.69) 1.16 (0.56- 2.38) 1.29 (0.57- 2.94) 
 
0.59 (0.28- 1.20) 1.20 (0.54- 2.69) 1.03 (0.50- 2.10) 0.94 (0.55- 1.61) 
Both 0.49 (0.09- 2.67) 0.78 (0.46-1.33) 0.94 (0.36- 2.44) 1.25 (0.52- 2.97) 1.44 (0.54- 3.90) 1.11 (0.48- 2.56) 0.62 (0.21-1.84) 0.96 (0.45- 2.08) 0.81 (0.45- 1.45) 
Parental 
Eczema 
         
Mother 
Eczema only 
1.19 (0.28- 4.96) 1.05 (0.67- 1.64) 0.76 (0.31- 1.84) 0.68 (0.35- 1.30) 1.01 (0.48- 2.13) 0.49 (0.26- 0.94) 1.66 (0.76- 3.65) 0.55 (0.26- 1.17) 1.05 (0.64- 1.71) 
Father Eczema 
only 




1.01 (0.14- 7.62) 0.74 (0.42-1.31) 0.87 (0.31- 2.42) 0.64 (0.26- 1.55) 0.78 (0.28- 2.16) 0.66 (0.28- 1.55) 0.43 (0.13- 1.42) 0.78 (0.32- 1.92) 1.50 (0.80- 2.81) 
NO2 
 (early life) 
0.85 (0.58- 1.23) 0.95 (0.85- 1.05) 0.98 (0.81- 1.19) 1.18 (0.99-1.41) 1.10 (0.91- 1.35) 1.11 (0.94- 1.31) 1.19 (1.01- 1.46) 1.00 (0.85- 1.17) 1.00 (0.88- 1.12) 
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Note. *Relative Risk Ratio (95% confidence intervals) and significance differences from the average trajectory were derived from a multinomial logistic 
regression. **Bold values indicate a significant association at α= 0.1, while bold and Italic at <0.05 ***LRTI= low respiratory tract infections, URTI= 







6.1 Discussion of findings 
There is a growing body of evidence that a proportion of chronic lung disease in adults 
has its roots in childhood. This is in line with the Development Origins of Health and 
Disease (DoHaD) theory first proposed by Barker and colleagues in 1989 (Barker et 
al., 1989). According to this concept, our health is influenced by the early-life 
environment in which we live, and by the events occurring in utero and in early 
childhood.  
 
Normal lung function development is characterized by a growth phase in which lung 
function grows, reaching a peak during early adulthood, a plateau phase, and a steady 
decline due to aging (GOLD, 2017). Normal ageing of the lung is associated with 
structural remodeling due to cell senescence resulting in reduced respiratory function. 
However, disadvantageous conditions during the intrauterine period and the first years 
of life might influence the lifetime lung function trajectory of an individual. The factors 
that may be implicated in poor lung health include respiratory infections, 
environmental tobacco smoke, adverse dietary intake, premature birth, air pollution and 
asthma (Stocks & Sonnappa, 2013). The contribution of this research is to identify 
people who follow an abnormal lung function growth trajectory as early as possible 
and investigate specific early-life factors associated with abnormal lung function.  
 
In this thesis, I aimed to establish lung function trajectories from childhood to young 
adulthood within the Raine Study cohort (Western Australia) and to explore childhood 
and parental risk factors as well as environmental pollution predictors associated with 
the low lung function trajectories identified. In Chapter 3, I identified lung function 
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trajectories using spirometry measurements that have been undertaken at 6, 14, and 22 
years of age. By using a finite mixture modelling, I have identified lung function 
trajectories for FEV1, FVC, and FEV1/FVC, respectively. In Chapter 5, I aimed to 
explore early-life predictors associated with the low lung function trajectories 
identified. Within the scope of this study, I have carried out the back-extrapolation of 
LUR models and estimated the individual exposure to environmental air pollutants, 
such as NO2, PM2.5, and PM2.5Absorbance for the study participants, as reported in Chapter 
4. 
 
To the best of our knowledge, this study described for the first time lung function 
trajectories from childhood to young adulthood for three respiratory outcomes, FEV1, 
FVC and FEV1/FVC in z-scores, and explored early life predictors associated with the 
trajectories identified, including individual early-life exposure to ambient air pollution. 
Four distinct trajectories were found for FEV1, FVC and FEV1/FVC from 6 to 22 years 
of age in the Raine study participants. Trajectories of FEV1 and FVC were similar in 
shape and were labelled as “very low”, “low”, “average”, and “above average”. The 
shape of the trajectories of FEV1/FVC differed from FEV1 and FVC and were 
characterized as “low”, “low-high”, “high-low”, and “average” trajectories. Asthma, 
maternal smoke and parental asthma were identified as risk factors for low lung 
function trajectories in this cohort study, as well as early exposure to NO2 – but not 
PM2.5Absorbance.  
  
Up to now, only a few studies have investigated lung function trajectories over time, 
with FEV1 being the most common respiratory outcome reported (Bui et al., 2018; 
McGeachie et al., 2016). Only one study explored FEV1, FVC, and FEV1/FVC 
trajectories and compared them using these different markers. Unlike our study, the 
respiratory outcomes were not measured in z-scores, hypothesized to be the most 
clinical meaningful approach (Vaz Fragoso et al., 2016) and their trajectories did not 
include the childhood period as the trajectories were modelled between 10 and 26 years 
of age (Karmaus et al., 2019). Similar to our study, FEV1/FVC differed from other 
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trajectories in that they showed a stable decline from puberty to young adulthood. 
Indeed, both FEV1 and FVC trajectories seem to gradually increase from 6 to 22 years 
of age. In the Tasmanian Longitudinal Health Study (TAHS), Bui and colleagues 
identified six trajectories in individuals followed from 5 to 53 years of age, of which 
two (the early below average, accelerate decline and early low, accelerate growth, 
normal decline) were previously unknown. This difference from our study most likely 
due to the age range in TAHS being wider and participants being older than our study 
population. Thus, we could not identify these two trajectories in our cohort.  
Results from our analysis showed that our population was clustered into 
discrete trajectories from childhood to adulthood suggesting that events in the first 
years of life might have a role in influencing the lung function trajectories and that they 
may be partly established before six years of age.   
 
Data from this thesis revealed associations between childhood, parental and 
environmental factors and the trajectories identified. Specifically, asthma, maternal 
smoking during gestational period or childhood, and parental asthma were found to be 
risk factors for low lung function trajectories in this cohort study. Other respiratory 
symptoms, such as childhood wheeze was prevalent in the very low trajectory of FEV1 
compared with the average category. Further, all the three asthma phenotypes, such as 
early-onset asthma, persistent and late-onset asthma were prevalent in the very low 
trajectory of FEV1/FVC, compared with the average trajectory. Early-life exposure to 
low concentration of NO2 was found to be associated with low lung function 
trajectories of FEV1/FVC in our cohort- but not with FEV1 or FVC. A wide range of 
studies demonstrated the linked between the adverse effects of air pollution on lung 
function cross-sectionally, while this study adds to relatively small body of literature 
investigating the impact of early post-natal environmental air pollution into young 
adulthood. Perth is an area with relatively low concentrations of pollutants such as 
PM2.5, PM2.5Abs and NO2, that were also below the WHO guidelines and some 
limitations in the use of LUR such as its development in a subsequent period were 
addressed.  Further, we were not able to capture other potential crucial periods, such as 
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the gestational and the first years of life in which lung morphology undergoes dramatic 
changes. Indeed, one of the limitations encountered is that we could not back-
extrapolate air pollution data to pregnancy and in the first three years of life as 
monitoring measurements for PM2.5 and NO2 were consistently available only from 
1995 for PM2.5 and from 1993 for NO2. We defined early life exposure when children 
were aged between three and four years of age. More studies should be conducted both 
in low and high-level concentrations in order to further our understanding of the long-
term effects of air pollution exposure at specific periods, especially before and after 
birth.  
 
All these findings together, provide further insight into the emerging knowledge of lung 
function trajectories for different respiratory markers. The association between 
childhood/parental/environmental predictors and low lung function trajectories 
contributed to strengthen the hypothesis that early-life factors might influence adult 
respiratory health. Knowing the early-life risk factors associated with the lung function 
trajectories might serve as a purpose to prevent and tackle deficits in later life. As it has 
been previously demonstrated that low lung function trajectories of FEV1 contributed 
75% to participants diagnosed with COPD in adulthood (Bui et al., 2019), special 
attention would be given to participants belonging to the very low trajectory of FEV1 
who might be potentially at higher risk. The practical relevance of this study is the 
opportunity to identify those children who have a higher risk to be in the low 
trajectories, and consequently prevent future respiratory deficits. As the Raine Study is 
still on-going, it will be worth to investigate the association between lung function 
trajectories and diagnosis of COPD when the participants will reach an older age.  
 
6.2 Strengths, limitations, and future directions 
One of the major strengths of this study was the availability of a longitudinal dataset 
from a large cohort that allowed us to investigate the early risk factors associated with 
the lung function trajectories defined over time. The Raine Study, established in 1989 
in Perth (Western Australia), is one of the largest prospective cohorts of pregnancy, 
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childhood, and adolescence to be carried out anywhere in the world. Its long 
observation period of 22 years, compared with shorter periods in other studies, allowed 
us to determine the lung function trajectories from pre-school children into young 
adulthood. Indeed, only one study had a wider study period with lung function 
measured between 7 and 53 years (Bui et al., 2019). Due to the extensive period of 
follow up, we were also able to acquire predictor variables that were related to 
childhood and parental respiratory health, as well as demographics and individual 
addresses at each follow-up.  
Further, while prior studies investigated only one respiratory health outcome, 
this study provided trajectories of FEV1, FVC, and FEV1/FVC using an unsupervised 
statistical method through group-based trajectory modelling. The advantage in using 
this novel approach, compared with other more traditional such as hierarchical 
modelling and latent curve analysis, is that this enabled us to identify meaningful 
subgroups within the population that follow distinctive trajectories that are not 
detectable a priori based on some measured characteristics (Nagin, 2014).  
 
This study has also some limitations. Although spirometry maneuvers are considered 
to be reliable and acceptable in pre-school children, one of the problems encountered 
when performing the test is that patients might be unable to exhale completely. Indeed, 
in our population sample, the forced vital capacity measured at six years seem to be 
underestimated, resulting in an overestimation of lung function trajectories of 
FEV1/FVC ratio. Another limitation we faced during this study was that we could not 
back-extrapolate air pollution data earlier than 1993, year in which most of our children 
population were aged three. Lung development starts in utero and the fetal and the first 
few years of post-natal life are considered crucial as the lung growth and development 
are rapid. Our aim was to investigate early life risk factors on lung function, and it was 
of our interest to explore the role of environmental pollution in utero and in the very 
early stage of life. However, due to the scarcity of monitoring air pollution data in the 
past, we were unable to back-extrapolate air pollution data before 1993 for 
PM2.5Absorbance and NO2. Further, despite various studies having demonstrated the 
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stability of LUR models for periods longer than 35 years, we were not able to assess 
the stability of our model as the 2012 LUR model used for this study was the only one 
developed and validated for the metropolitan area of Perth. 
 
6.3 Conclusions 
In conclusion, this study suggests that a distinctive group of individuals demonstrate a 
low lung function trajectory that may be partly established before six years of age or 
even, before birth.  
 
The use of an advanced novel statistical approach enabled the identification of lung 
function trajectories in the Raine Study cohort. We were able to identify four 
trajectories for FEV1, FVC and FEV1/FVC in an unsupervised manner. Lung function 
trajectories for FEV1 and FVC were similar in shapes, being characterized by a very 
low, low, average, and above average trajectories, where the low trajectory was the 
most populated trajectory. FEV1/FVC was characterized by a very-low, low-high, 
average, and high-low trajectories, based on their shape, where nearly half of 
participants were in the average trajectory. The FEV1/FVC trajectories showed an early 
decline for all trajectories during adolescence, that might be explained by reaching a 
relative higher FVC than FEV1 between 14 and 22 years of age.  
 
While prior studies investigated one lung function outcome at time, this study provided 
for the first time trajectories of FEV1, FVC, and FEV1/FVC, expressed in z-scores in a 
large population sample followed from childhood to young adulthood.  
 
We found that early-life predictors of low lung function trajectories were asthma, 
maternal smoke, parental asthma, and early-life exposure to NO2. In addition, 
childhood wheeze was associated with the very low trajectory of FEV1 and females 
were more likely to belong to the low trajectory of FVC compared with males. Other 
potential risk factors that we investigated, such as parental hay fever, parental eczema, 
and parental wheezing were not significantly associated with lung function trajectories 
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in this study cohort. These findings together support the hypothesis of the Development 
Origins of Health and Disease (Barker, 1989), in which our health is influenced by 
events happened in vulnerable periods, such as early childhood. Despite the risk factors 
that we choose to explore were potentially associated with low lung function 
trajectories, these are not exhaustive as there are many other potential risk factors that 
we did not include, such as diet, physical activity, or chemical exposure. To the best of 
our knowledge, this is the first study on lung function trajectories that also include 
individual early-life exposure to ambient air pollution.  
 
This thesis adds to the current knowledge showing trajectories along with several 
predictors assessed from 6 to 22 years of age. Investigating early life risk factors on 
lung function trajectories from childhood to young adulthood is critically important as 
a first step in preventing long term lung impairments and to identify children that might 
be at higher risk to develop deficits of lung function later in life. Indeed, as it has been 
shown that lung function track into adulthood, a particular attention should be drawn 
to those children belonging to the low trajectories of lung function.  
It is fundamentally important to develop strategies to promote optimum lung 
development. Indeed, prevention at an early stage of life is crucial to optimize healthy 
lung function after birth, in childhood into adulthood. For example, public and 
individual-level interventions should be put in place to avoid NO2 exposure in early 
life, as well as to avoid exposure to smoke, especially in children with asthma.    
Another practical implication of this study is that the generation of lung function 
trajectories of FEV1, FVC, and FEV1/FVC defined in this thesis for the Raine Study 
participants can also be used as an outcome for further investigations within the same 
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Gastritis and gastroesophageal reflux disease are 
strongly associated with non-allergic nasal disorders 
 
8.1 Introduction  
During my PhD from 2017 to 2020, I have been working within two research Institutes, 
the University of Verona (Verona, Italy) and the Telethon Kids Institute (Perth, 
Western Australia). The main research project reported in this thesis has been carried 
out during my stay in Australia and it has been fully reported from Chapter 1 to Chapter 
7. In this last Chapter, I will focus on the research conducted at University of Verona, 
focused on the gastritis and gastroesophageal reflux disease associated with non-
allergic nasal disorders. The work from this Chapter has been sent and accepted by the 
BMC Pulmonary Medicine Journal.  
 
8.2. Abstract  
Background: Gastroesophageal reflux disease (GERD) has been reported to be 
significantly associated with chronic rhinosinusitis, but the strength of the association 
is still debated. 
Aims: To evaluate the strength of the association between gastritis/GERD and non-
allergic rhinitis (NAR)/allergic rhinitis (AR)/sinusitis. 
Methods: We investigated 2887 subjects aged 20-84 years, who underwent a clinical 
visit in seven Italian centres (Ancona, Palermo, Pavia, Terni, Sassari, Torino, Verona) 
within the study on Gene Environment Interactions in Respiratory Diseases, a 
population-based multicase-control study between 2008 and 2014. Subjects were asked 
if they had doctor-diagnosed “gastritis or stomach ulcer (confirmed by gastroscopy)” 
or “gastroesophageal reflux disease, hiatal hernia or esophagitis”. The association 
between NAR/AR/sinusitis and either gastritis or GERD was evaluated through relative 
risk ratios (RRR) by multinomial logistic regression. 
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Results: The prevalence of gastritis/GERD increased from subjects without nasal 
disturbances (22.8%=323/1414) to subjects with AR (25.8%=152/590) and further to 
subjects with NAR (36.7%=69/188) or sinusitis (39.9%=276/691). When adjusting for 
centre, sex, age, education level, BMI, smoking habits and alcohol intake, the 
combination of gastritis and GERD was associated with a four-fold increase in the risk 
of NAR (RRR = 3.80, 97% CI 2.56-5.62) and sinusitis (RRR = 3.70, 2.62-5.23) with 
respect to controls, and with a much smaller increase in the risk of AR (RRR = 1.79, 
1.37-2.35). 
Conclusion: The study confirmed the association between gastritis/GERD and nasal 
disturbances, which is stronger for NAR and sinusitis than for AR. 
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Rhinitis is a global common problem and is defined as the presence of at least one 
of the following: congestion, rhinorrhea, sneezing, nasal itching, and nasal obstruction. 
The two major classifications are allergic (AR) and non-allergic rhinitis (NAR) [1]. 
NAR occurs when obstruction and rhinorrhea are related to non-allergic, non-infectious 
triggers such as a change in the weather, exposure to caustic odors or cigarette smoke, 
barometric pressure differences, etc. [2]. The prevalence of AR in adults in Europe 
ranged from 17% to 28.5% [3], while NAR affects up to 30% of individuals in the 
Western population [4]. 
Gastro-esophageal reflux disease (GERD) is also a worldwide prevalent condition, 
which is on the rise in Europe and North America [5]. Hence also esophageal and 
extraesophageal diseases associated with GERD are expected to increase. Some of the 
well-established extraesophageal manifestations are reflux-induced cough, laryngitis, 
asthma and dental erosion. Other manifestations, such as sinusitis, pharyngitis, 
idiopathic pulmonary fibrosis, and recurrent otitis media, are proposed but not 
established as it is unclear whether GERD is a significant causal or exacerbating factor 
[6].  
Since both chronic rhinosinusitis and GERD are highly prevalent, it is difficult to 
establish a direct relation between them, as they can easily coexist independently [7]. 
Moreover, while the association between GERD and nasal disorders gained support in 
children [8, 9], in adults the evidence is still sparse. Several studies focused on the 
possible correlation of GERD and sinusitis [10-12], which have been reported to occur 
together more frequently than expected [13]. At first, several reviews did not find out 
a clear evidence-based relationship between Chronic rhinosinusitis and GERD [13 – 
15]. However, in the last years the association between GERD and sinusitis gained 
support. Two European studies found that the SNOT (Sino-Nasal Outcome Test) score 
significantly increased among patients with GERD, suggesting a direct role of GERD 
in the development of chronic rhinosinusitis [10, 16]. A large cohort study based on 
Taiwan Health Care Utilization database by Lin et al. [17] found that the risk of 
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developing chronic rhinosinusitis was more than doubled in cases with newly 
diagnosed GERD with respect to controls matched for sex, age and comorbidities. In a 
population-based Brazilian survey the diagnosis of gastritis/ulcer/gastroesophageal 
reflux was associated with higher prevalence of rhinosinusitis symptoms in 
multivariable analysis [18]. An Italian study on a small series undergoing both nasal 
citology and esophageal manometry and 24-hour pH-impedance monitoring showed 
that NAR with neutrophils strongly correlated with higher acid exposure time and 
refluxes number [19]. On the basis of this accumulating evidence, the International 
Consensus Statement on Allergy and Rhinology: Rhinosinusitis [20] assigned grade B 
evidence to support the association between chronic rhinosinusitis and GERD, 
although causation could not be clearly demonstrated.  
The association between GERD and AR is more questioned. The recent 
International Consensus Statement on Allergic Rhinitis does not even mention GERD 
at all as a potential risk factor [21]. The situation is complex, as several studies which 
found an association between GERD and nasal disorders did not distinguish between 
NAR and AR [22]. 
Since nasal disorders are highly prevalent diseases that can have a deep impact on 
individual life and healthcare system, it is important to identify causative and triggering 
factors, and their comorbidities. The present study aimed to investigate the relation 
between gastritis/GERD and allergic and non-allergic rhinitis in a large population-




The study was performed in the frame of the GEIRD (Gene-Environment Interactions 
in Respiratory Diseases) study, a multicase-control study on respiratory health, 
involving seven Italian centers, three located in Northern Italy (Verona, Pavia, Turin), 
two in Central Italy (Ancona, Terni) and two in the major islands (Sassari in Sardinia 
and Palermo in Sicily) [23]. The study comprised a screening phase and a clinical 
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phase. In the screening phase a screening questionnaire was mailed to random samples 
from the general population aged 20-84 years, while in the clinical phase subjects 
reporting symptoms suggestive of chronic bronchitis, asthma or rhinitis, as well as a 
sample of subjects without respiratory symptoms, were invited to a local 
Respiratory/Allergy Unit, in order to undergo interviews and clinical tests. In 
particular, participating subjects were administered a modified version of the ECRHS 
(European Community Respiratory Health Survey) clinical questionnaire, including 
detailed questions on socio-demographic characteristics, smoking habits and other 
lifestyle factors, respiratory symptoms and other disturbances, drug consumption [23; 
available at www.geird.org]. In each center, the GEIRD study was approved by the 
local ethics committee and written consent was obtained from each participant. 
Fifty-nine percent (17,972 / 30,349) of selected subjects answered the screening 
questionnaire, while 2,945 subjects out of 7,739 participated in the clinical visit 
between 2008 and 2014, yielding a participation rate of 40.1%. 
 
Nasal disorders 
Subjects were classified as having "rhinitis" if they answered affirmatively to at least 
one of the following questions: "Do you have any nasal allergies including hay fever?", 
"During your lifetime have you ever had any nasal allergies including hay fever?", 
"Have you ever had a problem with sneezing, or a runny or a blocked nose when you 
did not have a cold or the flu?". Rhinitis was further classified as allergic rhinitis (AR) 
and non-allergic rhinitis (NAR), according to the presence or absence of atopy. 
Subjects were also asked whether they ever suffered from nasal polyps. 
Treatments for nasal disorders were assessed by the following questions "Have you 
used any of the following nasal medicines (e.g. nasal sprays, inhaled powders or drops) 
for the treatment of your nasal disorders?" and "Have you used any of the following 
pills, capsules, or tablets for the treatment of your nasal disorder?". 
 
Other respiratory disorders 
152 
 
Asthma was deemed present when the subject reported physician-diagnosed asthma. 
The disease was further classified in: current asthma if the subject took any medicine 
for asthma or had had an attack of asthma or reported any asthma-like symptom 
(wheezing, chest tightness or shortness of breath) in the previous 12 months; past 
asthma otherwise. 
Chronic cough and phlegm was defined by a positive answer to the question: “Have 
you had coughing and phlegm on most days for a minimum of 3 months a year and for 
at least 2 successive years?”. Doctor-diagnosed chronic bronchitis was defined by an 
affirmative answer to the question: “Have you ever been told by a doctor that you have 




Atopy was established by a positive skin prick test in which the following panel of 
allergens were used: Cupressus arizonica, Dermatophagoides pteronyssinus, Artemisia 
vulgaris, Dermatophagoides farinae, Ambrosia artemisifolia, Alternaria tenuis, 
Parietaria judaica, dog dandruff, Corylus avellana, cat, Olea europea, Betula verrucosa, 
Cladosporium herbarum, and Phleum pratense. The result was considered positive if, 




Subjects were classified as having gastritis if they answered positively to the question 
"Has a doctor told you having or have had gastritis or stomach ulcer (confirmed by a 
gastroscopy)?" Similarly, subjects were considered having gastroesophageal reflux 
disease (GERD) if they answered affirmatively to the question "Has a doctor told you 





Subjects were classified as normal weight (BMI <25 Kg/m2), overweight (25≤BMI<30 
Kg/m2), or obese (BMI ≥30 Kg/m2). They were considered active when reporting to 
exercise for at least 1 hour getting out of breath or sweating with a frequency of at least 
2-3 times a week. 
With regard to smoking habits, subjects were classified as 1) current smokers, if they 
reported to have smoked at least one cigarette per day or one cigar a week for as long 
as one year, and also in the last month; 2) ex-smokers if they had smoked the same 
minimum amount previously reported, but had stopped smoking for at least one month 
before the interview; 3) never smokers otherwise. As regards alcohol consumptions, 
subjects were classified as drinkers and nondrinkers. 
 
Statistical analyses 
Significance of the association between AR/NAR/sinusitis and potential risk factors 
was evaluated by Fisher's exact test or chi-squared test. The same statistical tests were 
used to evaluate the association between gastritis/gastroesophageal reflux and other 
risk factors. 
Multivariable analysis was accomplished by a multinomial logistic regression model 
[24], where the response variable was nasal symptoms: 0 = no symptom (base 
outcome), 1 = allergic rhinitis, 2 = non-allergic rhinitis, 3 = sinusitis. Gastroesophageal 
reflux (none / gastritis / reflux / both gastritis and reflux) was the explanatory variable, 
while sex, age (per 10 year increase), age at completing full-time education (<18, 18-
21, >=22 years), BMI (<25, 25-29.9, >=30 Kg/m2), smoking habits (never smoker, past 
smoker, current smoker), alcohol intake (nondrinker, drinker), were the potential 
confounders. Results were synthesized through the relative risk ratios (RRR), adjusting 
standard errors for intra center correlation. Analyses were performed with STATA 
statistical software, release 14 (StataCorp, College Station, TX, USA) and statistical 






Description of controls and cases of AR/NAR/Sinusitis, as a function of main risk 
factors 
2887 subjects participated in the clinical visit and they had a mean age (SD) of 
50.1 (13.2) years. Cases of AR and sinusitis were younger (mean age±SD = 46.0±11.8 
and 48.7±11.9 years, respectively) than controls and cases of NAR (52±13.7 and 
54.6±14 years, respectively) (p<0.001). Controls and cases of NAR had a lower level 
of education and physical activity, a higher prevalence of obesity than cases of AR and 
sinusitis. Atopy, which was used to define NAR and AR, had a prevalence of 27% in 
controls and 58% in cases of sinusitis. Nasal polyps were rare in controls and cases of 
NAR, and more common in cases of AR and sinusitis. Use of antihistamines and 
steroids was frequent among cases of AR, and rare among cases of NAR, while the use 
of vasoconstrictors was similar in the two groups. Sex, smoking habits and alcohol 
intake did not significantly differ between cases and controls (Table 1). 
 
Table 1. Number and percent of controls, cases of non-allergic rhinitis (NAR), allergic 















Sex     0.068 
Male 729 (51.5) 317 (53.5) 87 (46.3) 326 (47.2)  
Female 687 (48.5) 275 (46.5) 101 (53.7) 365 (52.8) 
Age     <0.001 
20-35 144 (10.2) 95 (16.1) 12 (6.4) 70 (10.1)  
35-45 339 (23.9) 194 (32.8) 34 (18.1) 218 (31.6) 
45-55 388 (27.4) 191 (32.3) 61 (32.5) 218 (31.6) 
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55-65 254 (17.9) 72 (12.2) 36 (19.2) 119 (17.2) 
≥65 291 (20.6) 40 (6.8) 45 (23.9) 66 (9.6) 
Time at stopping education (years)   <0.001 
<18 465 (33.1) 141 (24) 64 (34.8) 190 (27.7)  
(18-22) 498 (35.5) 222 (37.8) 68 (37) 267 (38.9) 
≥22 440 (31.4) 225 (38.3) 52 (28.3) 228 (33.3) 
BMI (kg/m2)     0.030 
<25  681 (49.9) 328 (56.6) 94 (50.5) 355 (53.4)  
(25-30) 475 (34.8) 187 (32.2) 62 (33.3) 236 (35.5) 
≥30 208 (15.3) 65 (11.2) 30 (16.1) 74 (11.1) 
Physical activity (times/week)    0.038 
<2-3 times 983 (69.9) 379 (64.6) 138 (74.2) 467 (67.9)  
≥2-3 times 423 (30.1) 208 (35.4) 48 (25.8) 221 (32.1) 
Smoking habits     0.577 
No smoker 684 (49.4) 305 (52.6) 81 (43.8) 333 (49.3)  
Ex-smoker 411 (29.7) 158 (27.2) 60 (32.4) 200 (29.6) 
Current smoker 290 (20.9) 117 (20.2) 44 (23.8) 142 (21.0) 
Alcohol intake (No/Yes)    0.158 
No drinker 875 (62.3) 349 (59.4) 121 (64.7) 399 (58.1)  
Drinker 529 (37.7) 239 (40.6) 66 (35.3) 288 (41.9) 
Atopy     <0.001* 
No 931 (72.7) ------------- 188 (100.0) 268 (41.9)  
Yes 349 (27.3) 592 (100.0) ------------- 372 (58.1) 
Nasal polyps (ever)    <0.001 
No 1396 (98.8) 564 (95.4) 185 (98.4) 632 (91.7)  
Yes 17 (1.2) 27 (4.6) 3 (1.6) 57 (8.3) 
Asthma     <0.001 
No 1807 (85.25) 225 (40.47) 109 (72.67) 328 (52.82)  
Yes 107 (8.39) 238 (42.81) 29 (19.33) 213 (34.30) 
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Past 81 (6.35) 93 (16.73) 12 (8.00) 80 (12.88)  
Chronic chough and phlegm    <0.001 
No 1.338 (95.1) 524 (88.81) 154 (83.24) 588 (85.59)  
Yes 69 (4.9) 66 (11.19) 31 (16.76) 99 (14.41) 
Doctor-diagnosed chronic bronchitis  0.562 
No 1236 (97.78) 521 (97.38) 156 (96.89) 587 (96.71)  
Yes 28 (2.22) 14 (2.62) 5 (3.11) 20 (3.29) 
Steroids (ever)     <0.001 
No 1302 (98.6) 422 (80.8) 160 (92.5) 491 (79.1)  
Yes 18 (1.4) 100 (19.2) 13 (7.5) 130 (20.9) 
Vasoconstrictors (ever)    <0.001 
No 1274 (96.4) 394 (75.3) 142 (81.6) 486 (77.8)  
Yes 48 (3.6) 129 (24.7) 32 (18.4) 139 (22.2) 
Antihistamines 
(ever) 
    <0.001 
No 1320 (99.7) 362 (69) 162 (93.1) 495 (78.8)  
Yes 4 (0.3) 163 (31.1) 12 (6.9) 133 (21.2) 
Significance of differences was computed by Fisher’s exact test or chi-square test. 
*computed only on controls and people with sinusitis. 
 
Description of controls and cases of gastroesophageal disorders, as a function of 
main risk factors 
People with gastritis and/or gastroesophageal reflux were older and had attained a 
lower education level than people without these disorders (Table 2). Women more 
frequently reported gastritis and gastroesophageal reflux than men. Gastritis and 
gastroesophageal reflux were more common, respectively, in current smokers and 
overweight people. 
Atopy and nasal polyps, the level of physical activity and alcohol intake did not 




Table 2. Number (percentage) of controls, cases of gastritis and gastroesophageal 















Sex     0.034 
Male 1101 (51.7) 131 (49.6) 159 
(51.3) 
118 (42.5)  
Female 1027 (48.3) 133 (50.4) 151 
(48.7) 
160 (57.6)  
Age     <0.001 
20-35 282 (13.3) 11 (4.2) 19 (6.1) 15 (5.4) 
 
35-45 601 (28.2) 61 (23.1) 78 (25.2) 70 (25.2) 
 
45-55 648 (30.5) 68 (25.8) 87 (28.1) 81 (29.1) 
 
55-65 323 (15.2) 46 (17.4) 61 (19.7) 63 (22.7) 
 
>65 274 (12.9) 78 (29.6) 65 (21.0) 49 (17.6) 
 
Time at stopping education 
(years) 
   <0.001 
<18   578 (27.4) 111 (42.4) 93 (30.4) 103 (37.5) 
 








BMI     0.021 










≥30 271 (13.2) 36 (14.1) 43 (14.4) 41 (15.2) 
 
Physical activity (hours/week)    0.112 




≥2/3  683 (32.4) 68 (26.0) 91 (29.6) 79 (28.5) 
 
Smoking habits     0.006 












    0.793 








Atopy     0.485 








Nasal polyps     0.238 




Yes 73 (3.4) 10 (3.8) 17 (5.5) 7 (2.5) 
 
Significance of differences was evaluated by Fisher’s exact test or chi-square test. 
 




Gastritis/gastroesophageal reflux were strongly associated with nasal disorders. 
The prevalence of gastritis/reflux was 5.9% in controls, it slightly increased to 7.5% in 
cases of allergic rhinitis and further to 18.1% and 15.8% in cases of NAR and sinusitis, 
respectively (Table 3).  
 
Table 3. Prevalence of gastroesophageal disorders (gastritis/GERD) in controls, 














Gastritis/reflux  <0.001 
No gastritis/GERD 1091 (77.2) 438 (74.2) 119 (63.3) 415 (60.1)  
Gastritis/GERD 323 (22.8) 152 (25.8) 69 (36.7) 276 (39.9)  
     Gastritis only 108 (7.6) 43 (7.3) 21 (11.2) 81 (11.7)  
     GERD Only 132 (9.3) 65 (11) 14 (7.5) 86 (12.5)  
    GERD and 
Gastritis 
83 (5.9) 44 (7.5) 34 (18.1) 109 (15.8)  
Significance of differences was evaluated by Fisher’s exact test or chi-square test. 
 
Multivariable analyses 
The combination of gastritis and GERD was associated with a four-fold 
increase in the risk of NAR (RRR = 3.80, 97% CI 2.56-5.62) and sinusitis (RRR = 3.70, 
2.62-5.23) with respect to people without these disorders, and with a much smaller 
increase in the risk of AR (RRR = 1.79, 1.37-2.35). The risk of nasal disorders was 
significantly increased, although to a smaller extent, in subjects reporting gastritis 
alone, while GERD was significantly associated with sinusitis but not with either NAR 
or AR (Figure 1). 
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As regards the other factors, the risk of NAR was higher in women than men 
(RRR=1.28, 1.19-1.37). Moreover, the risk of AR and sinusitis decreased with 
advancing age (RRR per 10-year increase=0.70, 0.63-0.79 and 0.79, 0.66-0.95, 
respectively). The risk of NAR was higher in current smokers than never smokers 
(RRR=1.48, 1.16-1.89), and in people with medium than low education (RRR = 1.12, 
1.00-1.26). With respect to normoweight, obesity was associated with a lower risk of 
AR (RRR = 0.75, 0.58-0.97) and sinusitis (RRR = 0.79, 0.65-0.95). The risk of sinusitis 
was slightly higher in past smokers than never smokers (RRR = 1.18, 1.01-1.38) and 
in alcohol drinkers than non-drinkers (RRR = 1.23, 1.02-1.47).  
Figure 1. Association between nasal disorders and gastritis/gastroesophageal reflux, 
estimated by a multinomial regression model, adjusting for sex, age, education level, 
BMI, smoking habits, alcohol intake. Columns are RRRs, bars are 95% Confidence 




The main findings of the present study are:  
1.Gastritis and GERD were strongly associated with non-allergic nasal diseases 
(NAR and sinusitis) and, to a much smaller extent, to allergic rhinitis, both in 
univariable and multivariable analysis. 
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2.The association was rather strong for the combination of gastritis and GERD, and 
rather weak for gastritis alone, and nearly absent for GERD alone. Subjects self-
reporting both gastrointestinal diseases had probably a more severe condition than the 
other subjects. 
3.Nasal polyps, while nearly absent in controls and cases of NAR, were found in 5% 
of cases of AR and 8% of cases of sinusitis. Their prevalence was not significantly 
affected by gastritis/GERD. 
4.The risk of AR and sinusitis decreased with advancing age and in obese people. 
As regards lifestyle factors, NAR was associated with current smoking, and sinusitis 
with alcohol consumption. 
The present multicase-control study showed that upper gastrointestinal disorders 
were strongly associated with non-allergic nasal disorders: the prevalence of gastritis 
and/or GERD was 22.8% in controls, only slightly increased in cases of AR (25.8%), 
and picked up in cases of non-allergic nasal disorders, such as NAR (36.7%) and 
sinusitis (39.9%). These findings were confirmed in multivariable analysis, where the 
combination of gastritis and GERD was associated with a nearly four-fold increase in 
the risk of NAR and sinusitis, while the risk of AR was less than doubled. 
These findings are in agreement with the current literature. As already mentioned, 
the association between chronic rhinosinusitis and GERD has been acknowledged by 
the International Consensus Statement on Allergy and Rhinology: Rhinosinusitis [20], 
although with moderate evidence. On the other hand, the association between AR and 
GERD is not even mentioned by the recent International Consensus Statement on 
Allergic Rhinitis [21]. A recent study supported GERD involvement in the 
development of NAR, since patients with NAR displayed a high level of pepsin in 
saliva samples, especially in the postprandial period, compared to healthy controls [4].  
Nasal polyps were not significantly related to gastritis/GERD in the present study. 
Accordingly, Lin et al. [17] the association between GERD and chronic rhinosinusitis 
was stronger in subjects without than with nasal polyps. 
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An interesting approach to the relation between GERD and nasal disorders consists 
in verifying whether treatment of GERD could improve nasal symptoms especially in 
chronic rhinosinusitis refractory to clinical or surgical treatment. However, a recent 
review assessed the effect of treatment with proton pump inhibitors (PPIs) on chronic 
rhinosinusitis symptoms in four longitudinal studies, and found conflicting results [25]. 
  
Pathophysiological mechanisms 
Several mechanisms have been proposed to explain the relation between acid reflux 
and chronic rhinosinusitis. Subjects with chronic rhinosinusitis have been shown to 
have more proximal gastroesophageal reflux than healthy controls [26].  
First of all, gastric acid exposure may exacerbate inflammation within the mucosa 
of the upper airways and sinuses and impair mucociliary motility, causing obstruction 
of sinus ostia and favouring recurrent infections [27 - 29]. 
A second mechanism could be vagally-mediated neuroinflammatory changes [11]. 
Autonomic dysfunction can lead to reflex sinonasal swelling and inflammation, leading 
to blockage of the ostia. Wong et al. [30] gave experimental support to this hypothesis, 
showing that infusion of saline with hydrochloric acid in the lower esophagus increased 
nasal mucus production and nasal symptom score. 
Also a role of Helicobacter pylori (H. pylori) has been proposed, as the 
microorganism has been detected not only in the stomach but also in oral and nasal 
mucosa [31]. In particular, H. pylori has been found in nasal polyps but not in control 
tissue [32], and in patients who have both GERD and chronic rhinosinusitis [33]. 
Moreover, H. Pylori causes not only gastritis but also systemic inflammation, which 
can involve also the nasal mucosa. 
Strengths and limitations 
The present study has several strengths. It involved seven centres scattered from 
Northern to Southern Italy, 1,471 cases of nasal disorders and 1,416 controls, and 
information was collected by standardized methods (questionnaire and skin prick test). 
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However, some limitations should be acknowledged. First of all, the cross-
sectional design did not allow to properly infer the cause-effect relationship between 
GERD/gastritis and NAR, Indeed, to prove such a cause effect relation, longitudinal 
studies with an adequate number of patients are needed. Second, while information on 
nasal disorders was based on questionnaire and objective measurement (skin prick test), 
information on gastritis and GERD was exclusively derived by questionnaire. Gastritis 
alone apparently had larger effects on AR and NAR than GERD alone. It should be 
reminded that the question on gastritis was probably more reliable as it involved not 
only medical diagnosis but also objective assessment (gastroscopy), while the question 
on GERD put together different diseases (GERD, hiatal hernia, or esophagitis) and did 
not refer to instrumentally confirmed diagnosis. Moreover, subjects who reported both 
gastritis and GERD probably had a more clear-cut gastrointestinal disease than those 
reporting only one disease. In turn, improvement in exposure definition allowed to 
better assess association with nasal disorders. 
 
Conclusions 
According to the present study, gastritis and GERD were strongly associated with 
nasal disorders, in particular non-allergic ones (NAR and sinusitis). On the other hand, 
AR, which was defined by symptoms and positive skin prick test, has an IgE-mediated 
pathogenesis and is only mildly affected by irritant substances, such as acid reflux. 
Nevertheless, to prove a causal effect relationship, prospective studies with a 
significant number of patients are needed. In particular randomized controlled trials 
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Ethics approval and consent to participate 
Ethics approval was obtained in each centre involved in the GEIRD study from the 
appropriate ethics committee (Comitato Etico dell’Azienda Ospedaliero-Universitaria 
Ospedali Riuniti di Ancona; Comitato Etico dell’Azienda Ospedaliera Ospedali Riuniti 
Villa Sofia Cervello di Palermo; Comitato di Bioetica della Fondazione IRCCS 
Policlinico San Matteo di Pavia; Comitato Etico delle Aziende Sanitarie dell’Umbria 
di Perugia; Comitato di Bioetica dell’Azienda Sanitaria Locale di Sassari; Comitato 
Etico dell’Azienda Sanitaria Locale TO/2 di Torino; Comitato Etico per la 
Sperimentazione dell’Azienda Ospedaliera Istituti Ospitalieri di Verona). 
Information on the purpose of the survey and participants’ rights according to then 
current Italian law (Decreto Legislativo 30 giugno 2003, n. 196) were enclosed to the 
questionnaire administered by mail. Individuals were free to answer or not answer the 
questionnaire, as denoted by the non-negligible nonresponse rate. Hence, consent to 
participate was implied by the answer to the questionnaire, and this form of consent 
was approved by the local Ethics Committee. 
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